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IDENTIFICATION OF A POST-TRANSCRIPTIONAL MECHANISM
REGULATING EPITHELIAL-MESENCHYMAL TRANSITION
George S. Hussey

ABSTRACT
A major challenge in the clinical management of human cancers is to
accurately stratify patients according to risk and likelihood of a favorable
response. Stratification is confounded by significant phenotypic heterogeneity in
some tumor types, often without obvious criteria for subdivision. Despite
intensive transcriptional array analyses, the identity and validation of cancer
specific ‘signature genes’ remains elusive, partially because the transcriptome
does not mirror the proteome. The simplification associated with transcriptomic
profiling does not take into consideration changes in the relative expression
among transcripts that arise due to post-transcriptional regulatory events.
Transcript-selective translational regulation of epithelial-mesenchymal transition
(EMT) by transforming growth factor- (TGF) is directed by the hnRNP E1containing

TGF-activated-translational

(BAT)

mRNP

complex.

Herein,

eukaryotic elongation factor-1 A1 (eEF1A1) is identified as an integral component
of the BAT complex. Translational silencing of Dab2 and ILEI, two EMTtranscripts, is mediated by binding of hnRNP E1 and eEF1A1 to their 3’-UTR
BAT element, whereby hnRNP E1 stalls translational elongation by inhibiting the
release of eEF1A1 from the ribosomal A site. TGF-mediated hnRNP E1

v

phosphorylation, through Akt2, disrupts the BAT complex, thereby restoring
translation of target EMT-transcripts. Attenuation of hnRNP E1 expression in
non-invasive breast epithelial cells induced not only EMT, but also enabled cells
to form metastatic lesions in vivo. Thus, translational regulation by TGF, at the
elongation stage, represents a critical checkpoint coordinating the expression of
EMT-transcripts involved during tumorigenesis and metastatic progression. Using
a genome-wide combinatorial approach involving expression profiling and RIPChip analysis, we have identified an EMT gene signature comprised of a cohort
of translationally regulated mRNAs that are induced during TGFβ-mediated EMT
and follow the same pattern of regulation as Dab2 and ILEI. Translational
regulation by hnRNP E1 constitutes a post-transcriptional regulon thus enabling
the cell to rapidly and coordinately regulate multiple EMT-facilitating genes.
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CHAPTER I
INTRODUCTION

1.1. TGF signaling and EMT
TGF, and its related factors, modulate essential cellular functions ranging
from cellular proliferation and differentiation to apoptosis (Shi & Massague, 2003;
Howe, 2003). TGF exerts its biological effects by inducing the formation of an
oligomeric complex of type I and type II serine/threonine kinase receptors. The
activated receptor complex phosphorylates and activates the receptor-regulated
Smads, Smad2 and Smad3. Once activated, these Smads complex with the
common mediator Smad4, translocate to the nucleus, wherein the Smads
regulate transcription of target genes through their interaction with a wide variety
of transcriptional regulators (Howe, 2003; Siegel & Massague, 2003). In addition
to the canonical Smad pathway, TGF has also been reported to signal through
components of the MAPK and PI3K/Akt pathways (Howe, 2003; Siegel &
1

Massague, 2003). TGF has been shown to activate extracellular signal
regulated kinase (ERK) (Hartsough & Mulder, 1995; Mucsi et al., 1996), Jun Nterminal kinase (JNK) (Afti et al., 1997; Hocevar et al., 1999), and p38 mitogen
activated protein kinase (p38) (Hanafusa et al., 1999). The TGF responses
regulated by these kinases are varied ranging from reporter construct
transactivation, to regulation of cellular proliferation and apoptosis. It has been
demonstrated that expression of the cytosolic adaptor molecule Disabled-2
(Dab2) was able to restore both Smad-dependent and Smad-independent TGF
responses to a TGF-signaling-deficient mutant cell line (Hocevar et al., 1999).
Human carcinomas exhibit a wide range of signaling events to promote
cell migration and invasion. Recent studies demonstrate the conversion of
epithelial cancer cells to a more mesenchymal-like phenotype, a process termed
epithelial-mesenchymal transition (EMT), to facilitate cell invasion and metastasis
(Brabletz et al., 2005). Numerous studies have suggested that members of the
TGF superfamily represent these inductive signals which mediate the transition
to a mesenchymal state (Sanford et al., 1997; Thiery and Sleeman, 2006). TGFinduced EMT is largely characterized by disruption of the polarized morphology
of epithelial cells and acquisition of a spindle shaped phenotype (Savagner,
2001). It is accompanied by a downregulation and relocalization of the epithelial
marker E-cadherin from cell junctions, whereas fibroblastic markers vimentin,
and N-cadherin are upregulated (Buck et al., 2007).
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1.2. Significance of Dab2 and ILEI in TGF-mediated EMT.
A predominant in vitro model for studying TGF-induced EMT is normal
murine mammary gland epithelial (NMuMG) cells. Using this model, two
candidate EMT genes were defined, Disabled-2 (Dab2) and FAM3C or
Interleukin like EMT inducer (ILEI). Dab2 is a cytosolic adaptor protein that is
involved in the organization and formation of signalsome complexes in clathrin
coated pits and in early endosomes following growth factor stimulation of cells. It
has also been shown to be an important regulator of cellular differentiation in
several models including megakaryocytic, visceral endoderm, and in EMT (Tseng
et al., 2001; Smith et al., 2001; Prunier & Howe, 2005). Dab2 is a positive
mediator of TGF signaling and functions as an adaptor protein bridging the
TGF receptor complex to the Smad proteins (Hocevar et al., 2001; Hocevar et
al., 2005). Treatment of NMuMG cells with TGF induces an alteration in cell
morphology from the cuboidal appearance characteristic of epithelial cells to an
elongated, spindle-shaped form characteristic of fibroblasts, and induces an
upregulation of Dab2 concomitant with EMT in these cells. Confirming the
morphologic analysis of a TGF-mediated EMT, treatment of cells with TGF
induces an accompanying increase in N-cadherin expression, characteristic of
fibroblastic cells (Prunier & Howe, 2005). ILEI was initially identified as a
candidate gene for autosomal recessive nonsyndromic hearing loss locus 17
(DFNB17) and was subsequently identified as a member of a recently discovered
gene family (FAM3A-D). In an expression profiling analysis of polysome boundmRNA during TGF-mediated EMT in EpRas cells, ILEI was shown to be
3

translationally upregulated during EMT (Waerner et al., 2006). This data
suggests that post-transcriptional control of Dab2 and ILEI gene expression is an
important regulatory mechanism and that translational control may be the
underlying mechanism.
1.3. Translational Control of Gene Expression.
Translation is usually initiated by binding of a cap-binding complex,
recruitment of the 40S small ribosomal subunit, scanning of the 40S subunit to
the first AUG initiation codon, and joining of the 60S large ribosomal subunit to
form a translational-competent 80S ribosome (Holcik & Sonenberg, 2005;
Gebauer & Hentze, 2004; Mazumder et al., 2003). Translational control can be
categorized into two general modes: global control, which regulates the synthesis
of many proteins; and transcript-specific control in which the translation of one (or
several) protein(s) is regulated. Global regulation occurs mainly through
modification of translation-initiation factors, whereas transcript-specific regulation
occurs by association with an RNA-binding protein to a cis-acting structural
element in the 5’- or 3’-untranslated region (UTR) of the target mRNA. In early
studies of cis-acting sequences that regulate translation, attention has been
mostly directed to the 5’-UTR. More recently, however, the 3’-UTR has become
increasingly recognized as an important regulator of mRNA translation
(Mazumder et al., 2003). Trans-acting factors that bind the 3’-UTR repress the
translation of multiple transcripts, including ceruloplasmin (Mazumder & Fox,
1999), 15-lipoxygenase (Ostareck et al., 1999), myocyte enhancer factor 2 (MEF2) (Black et al., 1997), -F1 ATPase (Izquierdo & Cuerva, 1997), amyloid
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precursor protein (Mbongolo Mbella et al., 2000), p53 (Fu & Benchimol, 1997)
and cyclin B (De Moor & Richter, 1999) to name a few. Recently, it has also been
reported that 3’-UTR-mediated translation control is a mechanism that is used to
modulate gene expression in a wide range of biological situations. From early
embryonic development to cell differentiation and apoptosis, translation has been
demonstrated to fine-tune protein levels in both a temporal and spatiallydependent manner (Preiss & Hentze, 1999; Mazumder et al., 2003; De Moor et
al., 2005).

5

CHAPTER II
IDENTIFICATION OF AN mRNP COMPLEX REGULATING
TUMORIGENESIS AT THE TRANSLATIONAL ELONGATION STEP1

2.1 Abstract
Transcript-selective translational regulation of epithelial-mesenchymal
transition (EMT) by transforming growth factor- (TGF) is directed by the
hnRNP E1-containing TGF-activated-translational (BAT) mRNP complex.
Herein, eukaryotic elongation factor-1 A1 (eEF1A1) is identified as an integral
component of the BAT complex. Translational silencing of Dab2 and ILEI, two
EMT-transcripts, is mediated by binding of hnRNP E1 and eEF1A1 to their 3’UTR BAT element, whereby hnRNP E1 stalls translational elongation by
inhibiting the release of eEF1A1 from the ribosomal A site. TGF-mediated
hnRNP E1 phosphorylation, through Akt2, disrupts the BAT complex, thereby

1
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restoring translation of target EMT-transcripts. Attenuation of hnRNP E1
expression in two non-invasive breast epithelial cells (NMuMG and MCF-7)
induced not only EMT, but also enabled cells to form metastatic lesions in vivo.
Thus, translational regulation by TGF, at the elongation stage, represents a
critical checkpoint coordinating the expression of EMT-transcripts required during
development and in tumorigenesis and metastatic progression.

7

2.2 Introduction
Metastasis is a process resulting in the spread of cancer cells from
primary tumors to distant sites and is responsible for more than 90% of cancerrelated deaths (Ma et al., 2010). Cells in the primary tumor are triggered by
stromal signals to undergo structural and phenotypic changes allowing them to
become more motile and invasive, ultimately leading to dissociation from the
primary tumor, invasion of surrounding tissue, intravasation into lymphatic or
vascular vessels, and extravasation and proliferation at secondary sites
(Mouneimne and Brugge, 2009). It is postulated that epithelial cancer cells revert
to an embryonic state during the invasive phase of metastasis, undergoing a
developmental switch from a polarized, epithelial phenotype to a highly motile
mesenchymal phenotype (Thiery and Sleeman, 2006). This epithelial to
mesenchymal transition (EMT) is induced by numerous cytokines, including
transforming growth factor- (TGF) (Massague, 2008). TGF-induced EMT is
indispensable during embryonic development for neural crest, heart, and
craniofacial structure formation (Massague, 2008), but can also be aberrantly
reactivated during tumorigenesis (Zavadil and Bottinger, 2005). TGF-mediated
EMT integrates Smad, as well as non-Smad signaling pathways (Bakin et al.,
2000) and is usually accompanied by a loss of epithelial cell markers; mainly Ecadherin and zonula occludens (ZO-1) (Massague, 2008) and expression of
different mesenchymal cell markers like N-cadherin and Twist (Yang et al., 2004;
Prunier and Howe, 2005).

8

Recent studies suggest that regulation of gene expression at the posttranscriptional level plays an important role in TGF-mediated EMT (Chaudhury
et al., 2010). We have described a transcript-selective translational regulatory
pathway

in

which

a

ribonucleoprotein

(mRNP)

complex,

containing

heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1), binds to a 33nucleotide (33-nt) structural element in the 3’-UTR of Disabled-2 (Dab2) and
Interleukin like EMT inducer (ILEI), two mRNAs involved in mediating EMT, and
inhibits their translation. The 33-nt RNA element, which we have designated
‘BAT’ for TGFbeta activated translational element, is sufficient to mediate
translational inhibition. TGF stimulation activates a kinase cascade terminating
in the phosphorylation of hnRNP E1, by isoform-specific stimulation of Akt2,
inducing its release from the 3’-UTR BAT element, resulting in reversal of
translational silencing and increased expression of these EMT-transcripts
(Chaudhury et al., 2010).
Herein, we identify eukaryotic elongation factor-1 A1 (eEF1A1) as an
integral component of the BAT mRNP complex. We demonstrate that the BAT
element, hnRNP E1 and eEF1A1 form a complex which mediates translational
silencing at the translational elongation step. Mechanistically, hnRNP E1 binding
to eEF1A1 effectively blocks progression of the 80S ribosome by preventing the
release of eEF1A1 from the ribosomal A site post GTP hydrolysis. Akt2-mediated
hnRNP E1 phosphorylation, following TGF stimulation, induces its release from
the BAT element and eEF1A1, allowing eEF1A1-mediated translational
elongation to proceed. Remarkably, modulation of hnRNP E1 expression, or its
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Akt2 targeted Ser43 phosphorylation site, transforms otherwise normal, nontumorigenic breast epithelial cells to highly invasive cells and enables these to
form tumor allografts with accompanying lung metastases.
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2.3 Results
eEF1A1 and hnRNP E1 are integral components of the BAT mRNP complex.
The isolation of hnRNP E1, its selective binding to the BAT element, and
its phosphorylation and release from the BAT element following TGF stimulation
has been described (Chaudhury et al., 2010). To identify other proteins in the
mRNP complex, we employed size exclusion chromatography, followed by in
vitro translation (IVT) analysis of a chimeric luciferase BAT (Luc-BAT) reporter
construct to isolate fractions that demonstrated translational silencing activity
(Figure 2.1 A, B). Cytosolic S100 extracts isolated from non-stimulated (-) murine
mammary epithelial (NMuMG) cells displayed translational silencing activity,
whereas lysates isolated from 24 h TGF-treated cells (+) did not (Figure 2.1 B).
Maximal translational silencing activity was observed in chromatography fractions
37-41 (Figure 2.1 B). These fractions were pooled and affinity purified by
precipitation with wild-type (WT) BAT cRNA or BAT mutant (BAT-M) coupled to
sepharose beads. The BAT-M contains a U to A substitution at position 10 that
by Mfold analysis is predicted to unfold the stem loop structure (Figure 2.1 B)
(Zuker, 2003). The precipitates were analyzed by SDS-PAGE and visualized by
silver stain (Figure 2.1 C, left panel). The resulting bands were compared to
corresponding bands in a silver stained gel of a BAT pull down from rabbit
reticulocyte lysate (RRL) (Figure 2.1 C, right panel). The lower band (~40 kDa)
corresponded with the previously identified BAT element binding protein hnRNP
E1. The band at ~50 kDa, present in pooled chromatographic fractions and RRL,
bound to the WT BAT, but not the BAT-M. The band was excised, subjected to
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mass spectrometric analysis and identified as eukaryotic elongation factor-1 A1
(eEF1A1). Additionally, we used two repetitive differentiation control elements
(DICE) (Ostareck et al., 1997) in an RNA pull-down experiment from RRL to test
the specificity of eEF1A1 binding to the BAT element. hnRNP E1 and
heterogenous nuclear ribonucleoprotein K (hnRNP K) have been shown to bind
to DICE in the 3-‘UTR of 15-lipoxygenase (Ostareck et al., 1997) and L2 mRNAs
(Collier et al., 1998) and mediate their translational regulation. DICE cRNA
precipitated hnRNP E1 and K (Figure 2.1 C, right panel), but not eEF1A1.
Immunoblot (IB) analysis of the chromatographic fractions confirmed that
eEF1A1 and hnRNP E1 eluted selectively in those fractions that exhibited
translational silencing activity (Figure 2.1 D).
In vitro reconstitution of translational silencing was performed with
eEF1A1 and hnRNP E1 in stoichiometric ratios to evaluate their indispensability
in rendering translational silencing activity. Purified eEF1A1 or recombinant fulllength (FL) hnRNP E1 expressed as a GST-fusion product, when excluded from
the reaction, or when added individually, had no effect on translational silencing
(Figure 2.1 E, lanes 1-3). eEF1A1 (1 – 4 pM) added with low doses (0.8 pM) of
hnRNP E1 also had no effect on translation of Luc-BAT (Figure 2.1 E, lanes 4-6);
however, eEF1A1 (1 pM) when added with increasing concentrations (1.2 – 3.2
pM) of hnRNP E1 resulted in translational silencing (Figure 2.1 E, lanes 7-9). The
last 3 lanes demonstrated that phosphorylated hnRNP E1 (p-hnRNP E1),
phosphorylated at Ser43 by recombinant Akt2 in vitro, when added with eEF1A1,
did not result in translational silencing.
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eEF1A1 interacts with hnRNP E1 and the BAT element in vitro and in vivo.
We examined the temporal association of eEF1A1 with hnRNP E1 and the
BAT element. WT BAT and BAT-M were used to precipitate eEF1A1 (Figure 2.2
A, top panel) or hnRNP E1 (Figure 2.2 A, middle panel) from NMuMG cell lysates
treated ± TGF. eEF1A1 and hnRNP E1 were both precipitated by WT BAT from
non-stimulated lysates, but TGF treatment induced the loss of eEF1A1 and
hnRNP E1 binding in a time-dependent manner. Additionally, purified eEF1A1
alone interacted with the WT BAT in a dose-dependent manner, but not with the
BAT-M (Figure 2.2 A, lower panel).
The kinetics of interaction between hnRNP E1 or eEF1A1 with the BAT
element were investigated using surface plasmon resonance (SPR) by BIAcore.
WT-BAT, BAT-M, and BAT-C (C26 point deletion which removed the asymmetric
bulge on the stem of the BAT element) were used in these analyses. The Mfold
generated structures of the WT-BAT, BAT-M, and BAT-C are depicted in Figure
2.2 B (Zuker, 2003). These cRNAs were synthesized carrying a 5’-biotin tag and
immobilized onto a streptavidin-coated sensor chip. FL-hnRNP E1, purified
eEF1A1, or p-hnRNP E1 were serially diluted to concentrations ranging from 1 500 nM, and injected across the ligand-immobilized surface. eEF1A1 and hnRNP
E1 displayed high affinity binding to the WT BAT, with diminished affinity for
either the BAT-M or BAT-C structural mutants (Figure 2.2 C, eEF1A1; K(a)(M)=
1.58 x 107; K(d)(M)= 6.32 x 10-8 ; hnRNP E1; K(a)(M)= 3.10 x 107; K(d)(M)= 3.22
x 10-7), whereas p-hnRNP E1 exhibited complete lack of binding to the WT BAT
or its derivative mutants (Figure 2.2 C, lower panel).
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In vivo interaction of hnRNP E1 and eEF1A1 in NMuMG cells treated ±
TGF was investigated by co-immunoprecipitation. Anti-hnRNP E1 coimmunoprecipitated eEF1A1 from cell lysates in a TGF- and PI3K-sensitive
manner (Figure 2.2 D). Interaction was observed in non-stimulated lysates but
lost, in a time-dependent fashion, in extracts from TGF-treated cells (Figure 2.2
D, top panel). Pre-treatment of cells with the PI3K inhibitor LY294002, blocked
the ability of TGF to modulate hnRNP E1/eEF1A1 interactions (Figure 2.2 D,
top panel), consistent with our previous observation that inhibition of the PI3K/Akt
pathway blocked hnRNP E1 Ser43 phosphorylation (Chaudhury et al., 2010).
TGF or LY294002 had no effect on the expression levels of hnRNP E1 and
eEF1A1 (Figure 2.2 D, lower panels).
In vitro binding studies were performed to confirm hnRNP E1/eEF1A1
binding and to determine respective interaction domains. FL-hnRNP E1
precipitated eEF1A1 in a dose-dependent manner (Figure 2.2 E, top panel) while
addition of BAT cRNA with low concentrations of eEF1A1 enhanced interactions,
suggesting that eEF1A1/hnRNP E1 interactions are stabilized in the presence of
the BAT element. p-hnRNP E1 failed to precipitate and interact with eEF1A1
(Figure 2.2 E, middle panel), indicating that phosphorylation of hnRNP E1
contributes to the attenuation of protein-protein and protein-RNA interactions.
We determined the domains of interaction between hnRNP E1, eEF1A1
and the BAT element. eEF1A1 and hnRNP E1 are RNA binding proteins with
well characterized domains (Dejgaard and Leffers, 1996; Yan et al., 2008).
eEF1A1 or its domains were expressed in vitro as [35S]-labeled products (Figure
14

2.3 A) and precipitated with FL-hnRNP E1 (Figure 2.3 B) or WT BAT (Figure 2.3
C); resolved by SDS-PAGE and analyzed by autoradiography. The results can
be summarized as follows; Domains 1 and 3 of eEF1A1, but not domain 2, bind
to hnRNP E1, whereas only domain 3 binds the BAT element.
Reciprocally, FL-hnRNP E1 and its KH1-3 domains were expressed as
GST-fusion products (Figure 2.3 D, left panel) and precipitated with WT BAT
(Figure 2.3 D, right upper panel) or eEF1A1 (Figure 2.3 D, right bottom panel);
resolved by SDS-PAGE and probed with -GST or -eEF1A1 antibodies,
respectively. The results can be summarized as follows: the KH1 and KH3
domains bind the BAT element (Figure 2.3 D, right upper panel), whereas KH1
and KH2 domains bind eEF1A1 (Figure 2.3 D, right bottom panel). A schematic
summarizing these results is depicted in Figure 2.3 F. Consistent with these
binding data, only FL-hnRNP E1 and its KH1 domain, which bound both eEF1A1
and the BAT element, were functional in repression of Luc-BAT in an IVT assay
(Figure 2.3 E). FL-hnRNP E1 repressed translation by >80%, whereas the KH1
domain repressed translation by ~70%. KH2 and KH3 domains were unable to
reconstitute translational silencing in vitro.
The BAT complex inhibits translation at the elongation stage
The effect of hnRNP E1/eEF1A1 interactions on translation elongation
were investigated. We created a synthetic construct harboring the WT BAT or
BAT-M element downstream of a poly(uridylic) acid template (poly(U)-BAT)
corresponding to (UUU)37 codons. poly(U)-BAT cRNA was used in an IVT assay
± hnRNP E1. These conditions allowed the ribosome to enter a correct reading
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frame by attachment to any three nucleotides of a UUU codon in the absence of
specific initiation and direct incorporation of [3H]-phenylalanine. Accumulation of
[3H]-Phe readily occurred in control reactions (Figure 2.4 A), whereas
incorporation of [3H]-Phe was inhibited when equimolar concentration of hnRNP
E1 relative to eEF1A1 was added to the reaction, and ~60% inhibition was
observed when 4X-fold excess of hnRNP E1 was added. As control, p-hnRNP
E1 did not inhibit [3H]-Phe incorporation (Figure 2.4 A). Furthermore, the poly(U)BAT-M failed to inhibit [3H]-Phe incorporation in the presence or absence of
hnRNP E1 (Figure 2.4 B).
Ribosome sedimentation analyses were performed to determine the
position of a stalled ribosome at either the initiation (40S) or elongation (80S)
stage of translation (Anthony and Merrick, 1992). A schematic of the procedure is
outlined in Figure 2.4 C. A 20-mer oligodeoxynucleotide was 5’-end labeled with
[-32P]-ATP and hybridized downstream of the AUG codon of Luc-BAT. The
hybrid was incubated with RRL to allow formation of ribosome-mRNA complexes.
As controls, the initiation inhibitor GMP-PNP and the elongation inhibitor
anisomycin were used to compare radioactivity profiles with reactions ± hnRNP
E1. Following incubation, the reaction was layered over a sucrose gradient,
centrifuged, and fractions collected from the top and used for scintillation
counting. In reactions containing GMP-PNP or anisomycin inhibitors, the [32P]labeled primer was detected in the 40S (initiation) or 80S (elongation) mRNA
complexes, respectively (Figure 2.4 D). In the absence of inhibitors and of
hnRNP E1, the [32P]-labeled primer segregated with the free RNA fraction with a
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minor 80S-mRNA peak observed, indicating that the primer had been displaced
from the hybrid, due to the helicase activity of the 80S ribosome, resulting in its
accumulation in the free RNA fraction (Figure 2.4 E). In the presence of hnRNP
E1, the ribosome-mRNA complexes co-sediment with the 80S fraction, indicating
that translation was stalled after formation of the 80S ribosomal complex (Figure
2.4 E). When p-hnRNP E1 was added to the reaction, the radioactivity profile
resembled that of the control reaction, indicating that p-hnRNP E1 had no effect
on progression of the 80S ribosome (Figure 2.4 F). These results provided
evidence that the BAT mRNP complex was targeting the elongation step of
protein biosynthesis.
To further localize the action of hnRNP E1, we examined eEF1A1dependent (enzymatic) and -independent (non-enzymatic) binding of aminoacyltRNA. Purified 80S ribosomes and poly(U)-BAT were incubated with [3H]-PhetRNAPhe in the presence or absence of eEF1A1 ± hnRNP E1. eEF1A1-dependent
and -independent binding of [3H]-Phe-tRNAPhe was not affected by the addition of
hnRNP E1 or p-hnRNP E1 (Figure 2.4 G), indicating that hnRNP E1 allows both
enzymatic and non-enzymatic binding of aminoacyl-tRNA. Additionally, we tested
the effect of hnRNP E1 on the intrinsic GTPase activity of eEF1A1, but found that
hnRNP E1 had no effect on GTP hydrolysis (Figure 2.4 H).
hnRNP E1 prevents the release of eEF1A1 from the ribosomal A site.
Since hnRNP E1 had no effect on aminoacyl-tRNA binding or GTPase
activity of eEF1A1, we hypothesized that it may be preventing release of eEF1A1
from the ribosome. To investigate this scenario, a ternary complex of Phe-
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tRNAPhe, eEF1A1, and [8-3H]-GTP was incubated with 80S ribosomes, poly(U)BAT ± hnRNP E1 to allow for at least one round of eEF1A1 binding, followed by
GTP hydrolysis and eEF1A1 release (Figure 2.5 A). The reaction mix was then
analyzed by gel filtration chromatography. This assay allowed us to monitor the
presence of eEF1A1 as either free, or ribosome-bound since [8-3H]-GTP retains
its radiolabel after hydrolysis, with the resultant [8-3H]-GDP remaining attached to
the elongation factor. Aliquots of each fraction were used to measure absorbance
at 280 nm, radioactivity via liquid scintillation, or for IB analysis. In control
reactions (Figure 2.5 B), eEF1A1 eluted in the lighter fractions (11-14), while the
ribosomes eluted in the heavy fractions (7-8) as indicated by the radioactivity
profile (graph) and IB analysis with -eEF1A1 or -ribosomal protein L30
(RPL30) (Figure 2.5 B). Thus, eEF1A1 is released from the ribosome. When
hnRNP E1 was added to the reaction, the radioactivity profile shifted towards the
heavy fractions indicating that the eEF1A1 eluted with the ribosomes (Figure 2.5
C; graph), and IB analysis confirmed the presence of eEF1A1 and hnRNP E1 in
the ribosomal fractions (Figure 2.5 C). When p-hnRNP E1 was added to the
reaction, no [3H] radiolabel was found associated with ribosomes (Figure 2.5 D;
graph), and IB analysis confirmed the presence of eEF1A1 in the light fractions
(Figure 2.5 D).
In a separate set of reactions, by replacing [3H]-GTP with [-32P]-GTP in
the ternary complex, we identified the form of the nucleotide bound to eEF1A1 as
GDP since [-32P]-GTP will lose its radiolabel upon hydrolysis. As shown, (Figure
2.5 B, C, D) the [32P] radiolabel eluted with the lighter fractions in the absence
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(panel B) or presence of hnRNP E1 (panel C) or p-hnRNP E1 (panel D),
confirming that hnRNP E1 had no effect on GTPase activity. These results
demonstrated that hnRNP E1 prevents the release of eEF1A1-GDP from the
ribosome thus blocking translation at the eEF1A1-dependent elongation step.
Modulation of the BAT complex alters in vivo inhibition of translation
elongation.
We examined whether modulation of hnRNP E1 levels in cells regulated
translation elongation in vivo. We utilized NMuMG cells and derivatives of these
that we have previously described (Chaudhury et al., 2010), in which hnRNP E1
expression levels were either stably overexpressed (E23 cells), silenced by
shRNA (SH14 cells), or in which the silenced expression was rescued (knock-in)
with a wild-type (WT) (KIWT6 cells) or a phosphomutant form, (S43A
substitution) of hnRNP E1 (KIM2 cells). We investigated the effect of hnRNP E1
expression levels, or its phosphorylation status, on translational inhibition by
monitoring the translocation of ILEI mRNA from the non-translating, nonpolysomal pool to the actively translating, polysomal pool in non-stimulated and
TGF-treated cells (Figure 2.6 A). In NMuMG and KIWT6 cells, ILEI mRNA was
primarily associated with the non-polysomal fractions in non-stimulated cells but
translocated to the polysomal fractions after 24 h of TGF treatment. In SH14
cells, ILEI mRNA was abundant in the polysomal fractions irrespective of TGF
treatment, whereas in E23 and KIM2 cells, ILEI mRNA failed to translocate to the
polysomal fractions even in the presence of TGF.
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In cell-free IVT assays (Figure 2.6 B), cytosolic extract from nonstimulated NMuMG and KIWT6 cells inhibited translation of Luc-BAT, an
inhibition that was reversed after a 24 h TGF treatment. Extracts from SH14
cells failed to inhibit translation of Luc-BAT even in the absence of TGF,
whereas translational silencing was observed even in the presence of TGFtreated E23 and KIM2 cell extracts. Furthermore, supplementation of the SH14
extracts, or the TGF-treated NMuMG and KIWT6 extracts with nonphosphorylated FL-hnRNP E1 was able to reconstitute translational silencing.
Ribosome sedimentation analyses were performed to determine if extracts
from hnRNP E1-modulated cells could affect the ribosome association status of a
target mRNA (Figure 2.6 C). In reactions containing extracts from non-stimulated
NMuMG cells, the [32P]-labeled primer segregated in the 80S (elongation)
fraction, whereas only a minor 80S peak was observed in reactions containing
extracts from TGFtreated NMuMG cells (Figure 2.6 C; left top panel).
Supplementation of TGF-treated NMuMG extracts with FL-hnRNP E1 caused
the [32P]-labeled primer to again co-sediment with the 80S fractions, thereby
blocking translation at the elongation step (Figure 2.6 C; right top panel).
Alternatively, in reactions performed in the presence of SH14 cell extract, the
[32P]-labeled primer segregated with the free RNA fraction (Figure 2.6 C; left
bottom panel), while supplementation of SH14 extracts with FL-hnRNP E1
caused the ribosome-mRNA complexes to co-sediment with the 80S fraction. In
reactions containing extracts from E23 cells, the [32P]-labeled primer was
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detected in 80S (elongation) mRNA complexes irrespective of TGF-treatment
(Figure 2.6 C; right bottom panel).
As depicted in our model (Figure 2.6 D), eEF1A1 forms a complex with
hnRNP E1 and the BAT element. Given the necessity for cognate-codon
interaction with the ribosomal A site, it is likely that the formation of the BAT
mRNP complex occurs post-delivery of the aminoacyl-tRNA to the ribosome. The
ability of the BAT mRNP complex to inhibit eEF1A1-dependent elongation
suggests that the 3’-UTR is interacting with the 5’-UTR in a circularized model to
facilitate its proximity to the 80S ribosome. It has been suggested that
translatable mRNAs are likely to be found in circular forms due to interaction
between PABP, eIF4G, and the cap binding protein eIF4E (Wells et al., 1998). In
addition, numerous studies have demonstrated the importance of mRNA
circularization in translational regulation, most notably during expression of
ceruloplasmin in the GAIT-mediated translational regulatory system (Mazumder
et al., 2003). While such a circularized model remains to be firmly established,
our preliminary data is suggestive of such a scenario in that the poly(A) tail is
required for efficient translational silencing (Figure 2.7).
Modulation of the BAT complex alters in vitro migratory and invasive
capacity and in vivo tumorigenesis and metastasis.
Since acquisition of the mesenchymal state is associated with changes in
the proliferative, invasive, and migratory properties of cells, we investigated these
phenotypes using a combination of in vitro assays. In proliferation assays, SH14
cells resulted in a 2X-fold increase in the proliferative index compared to the
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parental or derivative clones of NMuMG cells (Figure 2.8 A). In TGF-mediated
wound healing migration assays, SH14 cells resulted in complete wound closure
in 24 h, even in the absence of TGF, suggestive of an inherent migratory
capacity (Figure 2.8 B). In NMuMG and KIWT6 cells, wound closure was
observed only following a 24 h TGF treatment, whereas in E23 and KIM2 cells,
wound closure was not observed even in the presence of TGF, suggesting that
they were deficient in migratory capacity (Figure 2.8 B). In trans-well in vitro
invasion assays, SH14 cells were invasive even in the absence of TGF,
whereas the NMuMG and KIWT6 cells showed invasiveness only when TGF
was added to the lower chamber (Figure 2.8 C). In this assay, E23 and KIM2
cells failed to invade the basement membrane under all conditions. To assess
anchorage-independent growth, we performed soft-agar colony-formation assays
(Figure 2.8 D). Only the SH14 cells formed colonies in the absence of TGF,
whereas NMuMG and KIWT6 cells formed colonies only in the presence of
TGF.
Anchorage-independent growth in soft agar is often predictive of
tumorigenicity in vivo; we therefore inoculated NMuMG cells and hnRNP E1modulated derivatives subcutaneously into 6-week old athymic nude mice and
compared rates of tumor growth. The SH14 allograft induced large, slowly
growing tumors (n=5) with a mean volume of 198 ± 16 mm3, while NMuMG, E23,
KIWT6 and KIM2 cells only formed small, rapidly regressing nodules (Figure 2.8
E & Figure 2.9 A) at 96 days post-inoculation. SH14 cells formed tumors in >75%

22

of inoculations and these tumors reached a mean volume nearly 10X-fold that of
the KIWT6 allograft at 96 days post-inoculation (p<0.05) (Figure 2.9B).
Hematoxylin and eosin (H&E) staining revealed that tumors produced by
the SH14 cells were characterized by accelerated growth, decreased
differentiation, and acquisition of a spindle phenotype in comparison to the slow
growing, well differentiated and regressing nodules formed by NMuMG cells
(Figure 2.9 C, top panel). Immunohistochemical (IHC) staining of tumor sections
revealed an overall pattern suggestive of an in vivo EMT in SH14 injected mice,
including increased vimentin and ILEI staining, and loss of E-cadherin (Figure 2.9
C, bottom three panels). IB analysis of SH14 cells and cultured tumor cells from
SH14 injected mice displayed increased vimentin and ILEI expression and
decreased E-cadherin and hnRNP E1 expression as compared to parental
NMuMG cells (Figure 2.9 D).
We investigated whether modulating hnRNP E1 levels can directly dictate
in vivo metastasis, distinct from effects on tumor initiation. We used the
tumorigenic but non-invasive human breast cancer cell line MCF7 (Micalizzi et
al., 2009), and generated a stable shRNA-mediated hnRNP E1 knockdown
(MCF7 E1-/-) derivative. The MCF7 E1-/- cells displayed increased expression of
ILEI and the EMT marker vimentin compared to the parental MCF7 cells (Figure
2.10 A). The parental MCF7 and NMuMG cells, as well as their hnRNP E1
knockout derivatives, SH14 and MCF7 E1-/-, were stably transfected with a
constitutively

expressed

luciferase

construct

(Figure

2.10

B);

injected

intravenously (tail vein) into nude mice (1 x 105 cells/injection) and analyzed for
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metastasis following 30 days. As detected by in vivo bioluminescence imaging
(Figure 2.10 C), no metastases were observed in nude mice injected with
parental MCF7 or NMuMG cells, whereas metastases were observed in mice
injected with MCF7 E1-/- or SH14 cells (Figure 2.10 C). Ex vivo bioluminescence
imaging (Figure 2.10 D) detected metastatic lesions in lungs of mice injected with
MCF7 E1-/- or SH14 cells, whereas no lesions where detected in mice injected
with the parental lines (Figure 2.10 D). Together, these results suggest that
shRNA-mediated silencing of hnRNP E1 alters in vivo EMT and enables distant
organ colonization.
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Figure 2.1: eEF1A1 and hnRNP E1 are integral and functional components of the mRNP
complex. (A & B) Purification of the mRNP complex binding to the BAT element by size
exclusion chromatography of S100 cytosolic extract prepared from non-stimulated NMuMG
cells followed by IVT assay for translation inhibitory activity of Luc-BAT cRNA. Protein content
of chromatographic fractions was quantitated at 280 nm () and compared to protein
standards; translation inhibition was quantitated by NIH ImageJ software and compared to
inhibitory capacity of unfractionated, control S100 extract (). (C) Silver stain of RNA pull down
from chromatographic fractions (left panel) or rabbit reticulocyte lysates RRL (right panel) with
WT BAT or BAT-M (D) IB analysis of chromatographic fractions with -eEF1A1 and -hnRNP
E1 antibody. (E) IVT analysis was performed using Luc-BAT cRNA and X. EF-1 mRNA as a
control.
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Figure 2.2: eEF1A1 interacts with hnRNP E1 and the BAT element in vitro and in vivo. (A)
BAT RNA pull down from NMuMG cell lysates treated ± TGF (top panels), or from purified
eEF1A1 added at indicated concentrations (bottom panel) was separated by SDS-PAGE and
analyzed by IB with -eEF1A1 or -hnRNP E1 antibodies (B) Secondary structures of WT BAT,
BAT-C and the BAT-M element as predicted by the Mfold algorithm. (C) Binding of eEF1A1,
hnRNP E1, or p-hnRNP E1 to the BAT element was determined by SPR and expressed as
resonance units (RU). Sensograms of 500 nM protein binding to WT BAT, BAT-M and BAT-C
elements are overlayed. (D) Lysates prepared from NMuMG cells treated ± TGF for the times
indicated in the presence or absence of LY294002 were immunoprecipitated with -hnRNP E1
antibodies followed by IB analysis with -eEF1A1 (top panel) or -hnRNP E1 (middle panel). IB
analysis with -eEF1A1 antibody of whole cell lysate used in the co-immunoprecipitation analysis
(bottom panel). (E) GST pull down followed by IB analyses with -eEF1A1 antibody of GSThnRNP E1 (0.5 g) or GST-hnRNP E1 + BAT cRNA (100 ng) incubated with increasing
concentrations of purified eEF1A1 (top panel). GST pull down followed by IB analyses with eEF1A1 or -phosphoserine antibody of GST-hnRNP E1 (0.5 g) or in vitro Akt2-phosphorylated
GST-hnRNP E1 (0.5 g) with increasing concentration of purified eEF1A1 (lower panels).
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Figure 2.3: eEF1A1 and hnRNP E1 interact with each other and with the BAT element (A)
Mammalian expression versions of FL-eEF1A1, and eEF1A1 domain constructs eEF1A1-D1
(amino acids 1-239), eEF1A1-D2 (amino acids 240-328), eEF1A1-D3 (amino acids 329-462),
eEF1A1-D(1+2)(amino acids 1-328), and eEF1A1-D(2+3)(amino acids 240-462) were labeled in
35
vitro with [ S]-methionine, resolved by SDS-PAGE and analyzed by autoradiogram. (B, C) GST
35
and RNA affinity pull down of [ S]-methionine labeled eEF1A1 and key domain constructs.
Interactions were resolved by SDS-PAGE and analyzed by autoradiogram. RNA affinity pull down
(left panels) and GST pull down (right panels) using (D) Recombinant FL and key KH domains of
hnRNP E1 expressed as a GST fusion protein, resolved by SDS-PAGE and analyzed by
coomassie stain. RNA affinity and GST pull down assay (d, right panels) of full length hnRNP E1
and key KH domains. Interactions were analyzed by immunoblotting using a-EF1A1 and a-GST.
(E) In vitro luciferase assay. Capped and poly(A)-tailed template RNAs were translated in RRL
(Promega). Purified eEF1A1 (1pM), or recombinant GST-hnRNP E1 (3 pM), or GST-KH domains
1-3 (3 pM) were added and pre-incubated with the RNAs before addition of the translation
system. Recombinant GST (3 pM) was used as a control. Luciferase expression was detected by
luminescence. Data are presented as means ± s.e.m. for n=3 sample per group. (F) Model of the
protein-protein, protein-RNA interactions of eEF1A1, hnRNP E1 and the BAT element.
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Figure 2.4: hnRNP E1 and eEF1A1 inhibit translation at the elongation stage of protein
biosynthesis. (A) Translation of poly(U)-BAT mRNA was performed using RRL devoid of
3
added cold amino acids and supplemented with 5 mM MgCl2 and [ H]-phenylalanine, 1 pM
3
eEF1A1, and hnRNP E1 where indicated. The activity was measured as [ H]-phenylalanine
incorporation as a function of counts per minute (cpm). Data are presented as means ± s.d.,
n=3. (B) Translation of wild type (wt) versus mutant (M) poly(U)-BAT mRNA. Data are
presented as means ± s.d., n=3. (C) A schematic depicting the experimental procedure of 40S
and 80S ribosome sedimentation analysis. (D, E, F) Ribosome sedimentation analyses. The
efficiency of formation of the 40S and 80S ribosomal complexes was monitored via liquid
scintillation spectroscopy. The position of sedimentation of free RNA, 40S ribosomal subunits,
and 80S ribosomes are marked at the top of each figure. Graph of scintillation counts versus
sucrose gradient fraction number is represented for reactions in the presence of GMP-PNP, or
anisomycin-treated lysates (E); or for reaction reactions in the absence (control) or presence of
hnRNP E1 (E); and for reactions in the presence of p-hnRNP E1 (F). (G) Aminoacyl binding
assays. Activities ± eEF1A1 are denoted as enzymatic and non-enzymatic, respectively. Data
are presented as means ± s.d., n=3. (H) GTPase assay measuring effect of hnRNP E1 on
intrinsic eEF1A1 GTPase activity. Data are presented as means ± s.d., n=3.
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Figure 2.5: hnRNP E1 prevents the release of eEF1A1 from the ribosome. (A) Schematic
depicting the binding of eEF1A1 to the 80S ribosome, GTP hydrolysis and subsequent release
or arrest of eEF1A1 on the ribosome in the absence (control) or presence of hnRNP E1. A
Phe
3
ternary complex of Phe-tRNA -eEF1A1-[ H]-GTP was incubated with 80S ribosomes and
poly(U)-BAT in the absence (B) or presence (C) of hnRNP E1, and the resultant reaction mix
analyzed by gel filtration chromatography assay. p-hnRNP E1 was used as a control (D).
Aliquots of each fraction were used to determine absorbance at 280 nm () and for detection
3
32
of [ H] (), or [ P] radioactivity (∆). IB analyses of fractions were performed with antibodies
against eEF1A1, ribosomal protein L30 (RPL30), or hnRNP E1.
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Figure 2.6: hnRNP E1 expression levels control inhibition of translation elongation in vivo.
(A) Polysome profiling of parental and derivative NMuMG cells treated ± TGF. Translocation of
ILEI mRNA from the non-polysomal pool to the polysomal pool was analyzed by semiquantitative
RT–PCR. (B) In vitro translation (IVT) assay for inhibitory activity of Luc-BAT cRNA. Cell lysates
(5 g) were supplemented with FL-hnRNP E1 (0.5 g) where indicated, and pre-incubated with
the RNAs before addition of the translation system. X.EF-1 cRNA was used as an internal control.
(C) Ribosome sedimentation analyses. Graph of scintillation counts versus sucrose gradient
fraction number for reactions containing lysates from NMuMG, SH14, and E23 cells treated ±
TGF, and supplemented with FL-hnRNP E1 (0.5 g) as indicated. (D) Model depicting the BAT
regulatory mechanism (described in text).
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Figure 2.7: Poly(A) tail is required for efficient BAT-mediated translational silencing. In vitro
luciferase assay. 5'-capped and -/+ poly(A)-tailed Luc-BAT cRNAs were generated using the
mMessage mMachine transcription kit. The synthetic RNAs were translated in RRL. eEF1A1 (1
pM) and GST-hnRNP E1 (2 pM) were added as indicated and pre-incubated with the RNAs
before addition of the translation system. 10 l aliquots were used to detect luciferase expression
by luminescence. Data are presented as means ± s.e.m., n=3.
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Figure 2.8: hnRNP E1 expression levels control in vitro migratory and invasive capacity,
5
and in vivo tumorigenecity. (A) Cell proliferation assay. Cells (1 x 10 /well) of a particular cell
type were plated in a 6-well tissue culture plates, trypsinized and counted through a
hemocytometer chamber up to 12 days following initial seeding. Data is represented as means ±
s.e.m. of 3 independent experiments. (B) Wound healing assay. Cell monolayers were wounded
with a plastic tip after 24 h of seeding and images obtained using a phase-contrast microscope at
5X magnification. Cells were incubated ± TGF for 24 h at 37°C before being photographed again
5
at 5X magnification. (C) Cell invasion assay. Cells (2 x 10 ) were added to the membrane
chamber -/+ serum and TGF in the feeder tray. Cell invasion was assayed fluorimetrically at 480
nm/520 nm per manufacturer’s instructions. Data is represented as means ± s.e.m. of 3
4
independent experiments. (D) Anchorage-independent growth assay. Cells (1 x 10 ) were
suspended in 2 ml of 0.4% soft-agar in DMEM containing 10% FBS and were overlaid on 2 ml of
0.8% soft agar in 35 mm diameter dishes. Colonies were visualized under an inverted light
5
microscope after 3 weeks. (E) Subcutaneous inoculation of 1 x 10 cells in the hind flank (each
side) of six week old BalbC athymic nude mice (nu/nu). Tumor volume was determined 3 times a
week with a vernier caliper. Five animals were used for each cell type. Data is represented as
mean ± s.e.m. (n=5).
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Figure 2.9: hnRNP E1 expression levels alter in vivo tumorigenicity (A) Subcutaneous
5
inoculation of 1 x 10 cells in hind flanks of 6-week old BalbC athymic nude mice (nu/nu) was
3
performed. Images were taken 96 d post-injection. (B) Tumor volume (mm ) was evaluated as
Box-and-Whisker plot to analyze differences between median tumor volumes among the various
cells used for inoculation. Data are presented as means ± s.e.m (P< 0.05) for n=5 samples per
group. (C) H&E staining of excised tumors was performed according to standard protocols. IHC
of paraffin sections from excised tumors was performed with -E-Cadherin; -Vimentin; and ILEI. The stain was observed with a 40X objective lens. (D) IB analysis of NMuMG, SH14 and
cultured tumor cells from SH14 injected mice using -E-Cadherin, -Vimentin, -ILEI, -hnRNP
E1, and -Hsp90 antibodies.
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Figure 2.10: shRNA-mediated silencing of hnRNP E1 enables distant organ colonization.
(A) IB analysis of NMuMG, SH14, MCF7, and MCF7 E1-/- cells using -hnRNP E1, -Vimentin,
-ILEI and -Hsp90 antibodies. (B) In vitro luciferase expression in NMuMG, MCF7, SH14 and
MCF7 E1-/- cells stably transfected with the CMV firefly luciferase (Luc) construct compared to
the wild-type (WT) non-transfected cells. Data are presented as means ± s.d. (n=3). (C) In vivo
bioluminescent imaging of nude mice 30 d post intravenous injection. The luminescence signal
is represented by the overlaid false-color image. (D) Ex vivo bioluminescence imaging. Excised
lungs were imaged in a 35mm culture dish.
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2.4 Discussion
In the present study, we provide evidence for a regulatory mechanism in
which hnRNP E1 and eEF1A1 coordinate transcript-specific repression of genes
required for EMT. The canonical function of eEF1A1 is to facilitate binding of
aminoacyl-tRNA to the ribosomal A site in the form of a ternary complex,
eEF1A1-GTP-aminoacyl-tRNA (Negrutskii and El’skaya, 1998). Codon-anticodon
recognition is followed by GTP hydrolysis on eEF1A1, with subsequent release of
eEF1A1-GDP from the ribosome. Our data suggests that interaction between
eEF1A1 and hnRNP E1 inhibits eEF1A1 release following hydrolysis of GTP, so
that eEF1A1-GDP remains on the ribosome, thereby preventing the subsequent
translocation of the aminoacyl-tRNA to the peptidyl moiety of the growing peptide
chain. The ribosome is thus stalled at the eEF1A1-dependent elongation stage,
resulting in translational silencing. The interaction between eEF1A1 and hnRNP
E1 is largely mediated by their independent BAT element binding capacity, thus
allowing for a transcript-specific translational silencing activity in mRNAs which
harbor a 33-nt BAT element in their 3'-UTR. The transcript-specific restriction of
the BAT element is conferred by its structural fidelity rather than a conserved
sequence homology, as is evident by the fact that Dab2 and ILEI mRNA differ in
the nucleotide sequence of their respective BAT elements (Chaudhury et al.,
2010). Furthermore, the binding affinity of both hnRNP E1 and eEF1A1 is
impaired by mutations which alter the structure of the BAT element.
Insight into the structure-function relationships of eEF1A1 and hnRNP E1
may aid in providing an understanding of how hnRNP E1 prevents release of
eEF1A1 from the ribosome. Similar to other GTP-binding proteins, eEF1A1
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undergoes structural changes following hydrolysis. It has been shown that upon
GTP hydrolysis, domains 2 and 3 of eEF1A1 rotate as a rigid body with respect
to domain 1, thus resulting in a GTP-mediated conformational change (Berchtold
et al., 1993). In vitro binding studies demonstrated that hnRNP E1 is capable of
binding to eEF1A1 via its domains 1 and 3. Possibly, hnRNP E1 binding may be
affecting the interface of domain 1-3 in eEF1A1, thereby preventing the post-GTP
hydrolysis conformation change necessary for eEF1A1 release. It has also been
proposed that isoform-specific functions of elongation factor 1-alpha play an
important role in cancer (Edmonds et al., 1996), and while the eEF1A1 isoform
was used in the present study, we cannot rule out a potential role for eEF1A2 in
BAT-mediated translational silencing.
While translational regulation, through 5’ and 3’-UTR regulatory elements,
has most often been demonstrated to modulate the initiation stage, several
reports suggest that control may occur at the post-initiation level. For example,
the translational repression of nanos mRNA in Drosophila embryos has been
shown to be mediated by nanos 3’-UTR sequences, resulting in an altered
polyribosome profile, indicating a block after initiation of translation (Clark et al.,
2000). Additionally, during C. elegans larval development, repression of lin-14
mRNA has been shown to be directed by a small lin-4 RNA which binds the 3’UTR of lin-14 mRNA and mediates translational repression at a post-initiation
stage of translation (Olsen and Ambrose, 1999). Alternatively, in cell-free
translation assays, it has been demonstrated that phosphorylation of eukaryotic
elongation factor-1B, a guanine nucleotide exchange factor for eEF1A1, by
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CDK1/cyclin B, results in decreased elongation rates (Monnier et al., 2001).
While these examples are suggestive of regulation at an event post- initiation,
our identification of regulation being mediated at the elongation stage, precisely
through modulation of eEF1A1 function, provide a mechanistic demonstration of
such a translation control mechanism.
The biological implications of the BAT-mediated translational silencing
mechanism are profound. Both in vitro and in mice, knockdown of hnRNP E1 in
NMuMG caused these otherwise normal, non-invasive epithelial cells to display
an inherent tumorigenic and metastatic capacity. In allograftic tumor studies,
SH14 cells readily formed large, slowly growing tumors. In contrast, the parental
cells formed tiny, regressing nodules consisting of normal epithelial cells as
evidenced

by strong

E-cadherin

expression

in

tumor tissue

sections.

Downregulation of E-cadherin expression in SH14-derived tumors, as well as
upregulation of the EMT marker vimentin and strong expression of ILEI,
corroborate our morphological analysis and substantiate the findings that ILEI is
necessary for tumor formation (Waerner et al., 2006). In addition, knockdown of
hnRNP E1 in the human breast cancer line MCF7 caused these cells to acquire
EMT markers and to form lung metastases when injected intravenously. While
these results support a direct role for hnRNP E1 in EMT and metastasis, further
studies are needed to address earlier steps of metastasis such as invasion and
intravasation.
While the process of EMT in development and cancer progression has
been shown to encompass a wide continuum of alterations in epithelial plasticity
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in response to numerous signaling pathways, an important finding of this study is
that a single factor, hnRNP E1, is responsible for silencing a TGF-mediated
EMT program normally functional during embryonic development. Whereas Dab2
and ILEI protein expression is directly regulated by the BAT-mediated
translational silencing mechanism, our data suggests that the combined
expression of Dab2 and ILEI alone is not sufficient for mediating EMT
(Chaudhury et al., 2010). Rather, we postulate that the BAT regulatory
mechanism operates upstream of key cellular pathways contributing to
metastatic progression and tumor development.
An understanding of the molecular mediators that control epithelial
plasticity may aid in elucidating the downstream cellular pathways that are
affected by activation of silenced EMT-transcripts. A key step in EMT is
disintegration of adherens junctions associated with redistribution and repression
of the E-cadherin. (Thiery and Sleeman, 2006). Snail-related zinc-finger
transcriptional repressors (Snail and Slug), as well as bHLH transcription factors
Twist and E12/E47, are the most prominent suppressors of E-cadherin
transcription (Zavadil and Bottinger, 2005). Interestingly, a recent report has
demonstrated that translational regulation mediated by Y-box binding protein-1
(YB-1) is upstream of, and regulates the expression of transcription factors
implicated in repression of E-cadherin (Evdokimova et al., 2009). Enhanced
expression of YB-1 was shown to promote EMT and the metastatic potential of
normal breast epithelial cells by activating cap-independent translation of Snail1.
Similarly, our findings that shRNA-mediated knockdown of hnRNP E1 results in
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downregulation of E-cadherin and EMT, irrespective of TGF-treatment, may be
indicative of activated downstream EMT transcriptional programs leading to
downregulation of epithelial-related genes and activation of mesenchymal genes.
Numerous studies have shown that secretion of TGF by tumor cell-stimulated
autocrine loops and loss of sensitivity to the antiproliferative effects of TGF are
classical hallmarks during metastatic progression of tumors (Bierie and Moses,
2006). Additionally, activation of the PI3K/Akt pathway, as well as increased
expression of Akt2 have both been shown to lead to EMT and increased cell
invasiveness in tumor cells (Irie et al., 2005; Gershtein et al., 1999). Attenuation
of the BAT mRNP complex via TGF/Akt2-mediated phosphorylation of hnRNP
E1 may therefore represent a downstream target of cytokine-mediated
activation of EMT during tumorigenesis and metastatic progression. Although
our findings suggest that the proposed translational regulatory mechanism is
functionally significant in the metastatic progression of tumors, further studies
are needed to determine whether this pathway is deregulated in cancer cells
and tissues. Given the necessity of hnRNP E1 in the BAT mRNP complex we
speculate that expression levels and/or phosphorylation status of p-Akt2 and
hnRNP E1, as well as the expression of Dab2 and ILEI may be directly
correlative with metastatic progression of tumors.
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2.5 Materials and Methods
Reagents: Mouse -hnRNP E1 (1:3000) and -RPL30 (1:5000)
antibodies were obtained from Novus Biologicals. Rabbit -hnRNP E1 (1:3000)
was from Lifespan Biosciences. -ILEI was obtained from Abcam. phosphoserine (clone PSR-45; 1:1000) antibody was obtained from SigmaAldrich and -eEF1A1 (1:3000) from US Biologicals. -GST (#2622, 1:2000),
-Vimentin and recombinant Akt2 kinase were purchased from Cell Signaling
Technology. -E-Cadherin was purchased from BD Biosciences. -Hsp90 (H114, 1:5000), and normal mouse and rabbit IgG were purchased from Santa
Cruz Biotechnology. Secondary antibodies, -mouse and -rabbit-IgG-HRP
were obtained from GE Healthcare Bio-Sciences. Rabbit reticulocyte lysate and
RiboMAX Large Scale RNA Production kit were purchased from Promega.
MAXIscript and mMESSAGE mMACHINE T7 Ultra kits were purchased from
Ambion. Primers and oligonucleoties were purchased from Integrated DNA
Technologies. Translation grade [35S]-methionine, [-32P]-ATP and [-32P]-GTP
were purchased from Perkin Elmer Life Sciences. [ 3H]-phenylalanine and [83

H]-GTP was purchased from American Radiolabeled Chemicals, Inc.

LY294002 was obtained from Alexis-Biochemicals.
Cell culture and treatments: TGF2 was a generous gift from
Genzyme Inc. and was used at a final concentration of 5 ng/ml. NMuMG and
MCF7 cells, and all derivatives, were maintained in Dulbecco’s modified
Eagle’s medium supplemented with 10% fetal bovine serum, 10 g/ml insulin,
and antibiotics/antimycotics (100 units/ml penicillin G, 100 mg/ml streptomycin,
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and 0.25 g/ml amphotericin B). Where indicated, cells were treated with 10
M of LY294002 30 min before TGF treatment. SH14, E23, KIM2, and KIWT6
cells lines were generated in the laboratory and have been previously
described (Chaudhury et al., 2010).
Plasmids construction and protein expression: The 33-nt BAT, BATM, and BAT-C oligonucleotides were synthesized by Integrated DNA
Technologies with T7 promoter sequence, and annealed to a complementary
oligonucleotide containing the T7 promoter sequence in STE buffer (0.1 M
NaCl, 10 mM Tris-HCl [pH, 8.0], 1 mM EDTA). The oligonucleotides were
PAGE purified before annealing. The Luc-Dab2/BAT was generated in the
laboratory and has been previously described (Chaudhury et al., 2010). For
construction

of

the

poly(U)-Dab2/BAT,

TAATACGACTCACTATAGGG-

the

oligonucleotide

5'-

(TTT)37-TCCAAATACTCATAGCTCTCAAA

GTCATTTGGG-3’ was synthesized by Integrated DNA Technologies, and
PAGE purified. The oligonucleotide was amplified by PCR using 5’TAATACGACTCACTATAGGGTTTT-3’ and 5’-CCCAAATGACTTTGAGAGCT
ATG-3’ forward and reverse primers respectively, separated on a 2% agarose
gel, and purified using QiaQuick gel extraction kit (Qiagen). RiboMax kit
(Promega) was used to generate milligram quantity of cRNA. eEF1A1 purified
from human reticulocytes was maintained in #3344 buffer (100 mM KCl, 0.1
mM EDTA, 1 mM DTT, 20 mM Tris-HCl, pH 7.5, and 25% glycerol. pSilencer
neo-shRNA-human hnRNP E1-3’ UTR (shRNA against 3’ UTR of hnRNP E1)
was constructed by annealing shRNA template oligonucleotides and cloned

41

into pSilencer neo vector. pCMV-LL luciferase construct was generated as
previously described (Chaudhury et al., 2010).
Preparation

of

cell

lysates,

immunoblot

analysis,

and

immunoprecipitation: For immunoprecipitation and immunoblot analysis, cells
were lysed in buffer D and immunoprecipitation was performed as described
previously (Hocevar et al., 1999).
Preparation of cytosolic extract (S100 Fraction): S100 fractions were
prepared from control and TGF-treated NMuMG cells as previously described
(Mazumder and Fox, 1999) with minor modifications. Briefly, the buffer used for
cytosolic extraction contained 20 mM Hepes (pH 7.5), 10 mM KCl, 1.5 mM
MgCl2, 1 mM EGTA, 1 mM EDTA, 1 mM dithiothreitol and protease inhibitor
cocktail (Hampton et al., 1998).
Size-Exclusion chromatography: Size exclusion chromatography was
performed as described previously (Sampath et al., 2004). Briefly, 5 mg of
control cytosolic extract from NMuMG cells were applied to a Superose-6 FPLC
column and eluted at a flow rate of 0.5 ml/min. Ferritin (440 kDa), aldolase (158
kDa) and conalbumin (75 kDa) were used as molecular weight standards.
Fractions were subjected to in vitro translation reaction using pCMVLucDab2/BAT to assay for translation inhibitory activity.
RNA pull down: RiboMax kit (Promega) was used to generate milligram
quantity of synthetic 33-nt RNA from template DNA. WT BAT and BAT-M cRNA
were bound to CNBr-activated Sepharose beads and incubated with 100 g of
cytosolic extracts from NMuMG cells treated ± TGF for 2 h at 4 0C. Following
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incubation, beads were washed with 0.2 M NaCl and resolved by SDS-PAGE.
Size-exclusion fractions that displayed translational silencing activity were
subjected to RNA pull down as described above. The indicated bands were
excised,

and

peptide

sequences

determined

by

capillary

liquid

chromatography-electrospray mass spectrometry. The data obtained were
analyzed using TurboSequest software to query the NCBI nonredundant
protein database. Matching spectra was confirmed by manual interpretation
using Mascot and FASTA software.
In Vitro binding studies: GST-hnRNP-E1 (0.5 g) was immobilized
onto glutathione-agarose beads (Sigma), and incubated with indicated
concentrations of purified eEF1A1. The bead were then washed to remove
non-specific binding, and subjected to SDS-PAGE and IB analysis. The mouse
pGADT7-heEF1A1 and pGADT7 domain constructs eEF1A1-D1 (amino acids
1-239), eEF1A1-D2 (amino acids 240-328), eEF1A1-D3 (amino acids 329-462),
eEF1A1-D(1+2)(amino acids 1-328), and eEF1A1-D(2+3)(amino acids 240462) have been described previously (Mansilla et al., 2008). The constructs
were used to generate [35S]-methionine metabolically labeled proteins using the
TNT Quick Coupled Transcription/Translation system (Promega). The GSTtagged hnRNP E1 was a gift from Dr. Kumar and has been described
previously (Meng et al., 2007). The KH1-3 domain constructs of hnRNP E1
have been previously described (Sidiqi et al., 2005). The GST constructs were
expressed in E. coli, purified by affinity chromatography using Glutathione
Sepharose 4B beads (Amersham Biosciences) and eluted by 50 mM Tris (pH
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7.4) containing 10 mM reduced glutathione. Recombinant GST protein was
made in parallel for use in control experiments.
In Vitro luciferase assay: In vitro luciferase assay was performed as
described previously. (Mazumder and Fox, 1999) In brief, capped and poly(A)tailed template RNAs were generated using the mMessage mMachine
transcription kit. The synthetic RNAs were translated in RRL in the presence of
a methionine-free amino acid mixture and translation grade [35S]-methionine.
Indicated amounts of purified eEF1A1, or recombinant GST-hnRNP E1 were
added and pre-incubated with the RNAs before addition of the translation
system. Reactions were resolved by 10% SDS-PAGE and visualized by
autoradiography.
Polysome analysis: Polysome analysis was performed as described
previously (Merrick & Hensold, 2001). Briefly, cell lysates were layered onto a
10%-50% sucrose gradient and centrifuged at 100,000 x g at 4 0C for 4 h.
Gradient fractions were collected using a fraction collector with continuous
monitoring of absorbance at 254 nm. RNA was extracted with Trizol, and
analyzed by semiquantitative RT-PCR.
Surface Plasmon Resonance (SPR): SPR was performed using a
BIAcore 3000 optical sensor. Fifty response units (RU) of biotinylated cRNA
probe were immobilized onto a streptavidin-coated sensor chip (GE
Healthcare). Purifed eEF1A1 and GST-hnRNP E1 protein were diluted in HBSP buffer [0.01 M HEPES, pH 7.4, 0.15 M NaCl, 0.0005% Surfactant P20) to a
final concentration ranging from 1 to 500 nM, and injected for 120 seconds
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through four flow cells (flow cell 1, blank; flow cell 2; BAT-C; flow cell 3, BAT-M;
flow cell 4, WT BAT) at a flow rate of 25 l/min. The response value of the
reference cell (flow cell 1, blank) was subtracted from flow cells 2-4 to correct
for nonspecific binding. Association and dissociation rates were calculated
using BIAevaluation 3.0 software (BIAcore). Sensograms were transformed to
align injection points.
Poly(U)-directed synthesis assay: Translation of poly(U)-BAT was
performed as previously described (Monnier et al., 2001), with minor
modifications. In brief, RRL devoid of cold amino acids was supplemented with
5 mM MgCl2. Assays were performed with 1 Ci [3H]-phenylalanine (120
Ci/mmol), 2.0 g poly(U)-BAT cRNA, 14 l lysate extract, 1 pmol eEF1A1, and
1-4 pmol hnRNP E1 where indicated, in a total volume of 20 l and incubated
for 1 h at 30°C. 2 l aliquots were withdrawn from each reaction, and diluted in
1 ml decolorizing solution (0.5 N NaOH, 0.75% hydrogen peroxide). Samples
were precipitated with 1 ml cold 25% TCA (w/v) and filtered through Whatman
filters. Precipitated proteins were counted in scintillation fluid.
Sedimentation Analysis: Analysis using sucrose density gradients
were performed as previously described (Anthony and Merrick, 1992). Briefly,
Luc-BAT cRNA was hybridized to [32P]-ATP-end labeled 18-mer primer (5’GCTCTCCAGCGGTTCCAT-3’) complementary to a region 53-nt downstream
of the initiation codon. Labeled hybrid was incubated with RRL for 10 min at
30°C in the presence or absence of 0.1 mM Anisomycin (Sigma), 1 mM GMPPNP (Sigma), 80 pmol hnRNP E1, or 5.0 g cytosolic extract supplemented ±
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80 pmol GST-hnRNP E1 where indicated. Following incubation, the reaction
was layered on 10-35% linear sucrose gradients and centrifuged for 4 h at 4°C.
Gradients were fractionated (1 ml fractions) and 0.3 ml of each fraction was
counted via liquid scintillation spectrometry. A graph of scintillation counts
versus sucrose gradient fraction number was plotted to determine the quantity
of labeled primer present at each sedimentation coefficient (S) value.
Aminoacyl Binding assay: Aminoacyl binding assays were performed
as described previously (Agafonov et al., 2001) with some modifications.
Briefly, 15 pmol eEF1A1 were added to 100 l reaction mix containing 100 mM
KCl, 20 mM Tris-HCl, pH 7.5, 1.0 mM GTP, 2.1 mM phosphoenolpyruvate
(PEP), 0.3 U pyruvate kinase, 1 mM DTT, 10 mM Mg(CH3CO2), 0.5 A260 salt
washed ribosomes, 10.0 g poly(U)-BAT cRNA, 15 pmol [3H]-Phe-tRNA
(Escherichia coli; Sigma), and 30 pmol hnRNP E1. After 10 min incubation at
37°C, the reaction mixture was filtered through a 0.45 mm nitrocellulose
membrane and the filter-retained radioactivity measured. The non-enzymatic
[3H]-Phe-tRNAPhe binding was similarly performed, but eEF1A1 was omitted
from the reaction mixture.
GTPase Assay: Analysis of intrinsic GTPase activity was performed
using the QuantiChromTM ATPase/GTPase Kit from BioAssay Systems
according to the manufacturers protocol.
Gel Filtration on Sepharose 4B columns: Gel filtration on Sepharose
4B columns was performed as previously described (Wolf et al., 1977) with
minor modifications. Briefly, 100 pmol eEF1A1 were added to 150 l reaction
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mix containing standard buffer (100 mM KCl, 20 mM Tris-HCl, pH 7.5, 1 mM
DTT, 10 mM Mg(CH3CO2), 2.1 mM phosphoenolpyruvate (PEP), 0.3 U
pyruvate kinase, 150 pmol Phe-tRNA, 100 pmol [8-3H]-GTP (15 Ci/mmol), and
0.5 A260 salt washed ribosomes (RRL) were pre-incubated with 10.0 g poly(U)BAT cRNA, and 200 pmol hnRNP E1. Reaction was incubated 5 min. at 37°C;
chilled to 0°C and analyzed on Sepharose 4B columns equilibrated with
standard buffer. Fractions of 150 l were collected. Aliquots (15 l) were
dissolved in scintillation liquid and measured for radioactivity. Absorbance at
280 nm was determined on a NanoDrop 1000 Spectrophotometer (Thermo
Scientific).
Wound healing (migration) assay: Wound healing assays were
performed as described previously (Lamouille and Derynck, 2007) with brief
modifications. Cell monolayers were wounded with a plastic tip after 24 h of
seeding and images obtained using a phase-contrast microscope at 10X
magnification. The cells were incubated in a humidified chamber with 5%
carbon dioxide ± TGFβ for 24 h at 37°C before being photographed again at
10X magnification.
Cell proliferation assay: 1 x 105 cells/well were plated in triplicates in a
6-well tissue culture plate. Cells were trypsinized and resuspended in 1 ml of
media, before being counted through a hemocytometer chamber up to 12 days
following initial seeding. Data is represented as means ± s.e.m. of 3
independent experiments.
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Anchorage-independent growth assay (soft-agar colony formation
assay): Anchorage-independent growth assay was performed as described
earlier (Pietenpol et al., 1989). Approximately 1 x 10 4 cells were suspended in
2 ml of 0.4% soft-agar in DMEM containing 10% fetal bovine serum and were
overlaid on 2 ml of 0.8% soft agar in the same medium in 35 mm diameter
dishes. Each cell line was tested in triplicate wells. Colonies were visualized
under an inverted light microscope after 3 weeks.
Invasion assay: Cell invasion assay was performed using a
CytoSelect™ 96-well Cell Invasion Assay Kit (Cell Biolabs, San Diego, CA) as
per the manufacturer’s protocol. The experiment was performed with the
addition of the 2 x 105 cells to the membrane chamber and ± TGFβ in the
feeder tray. Cell invasion was assayed by using the provided cell lysis buffer
and CyQuant® dye fluorimetrically at 480 nm/520 nm. Data are presented as
means ± s.e.m. of 3 independent experiments.
Tumorigenesis

assay:

Tumorigenesis

was

determined

by

subcutaneous injection of 1 x 105 cells in the hind flank (each side) of 6-week
old BalbC athymic nude mice (nu/nu), according to approved protocols of
Institutional Animal Care and Use Committee (IACUC), Cleveland Clinic. Tumor
volume (mm3) was determined by using the standard formula a2 x b/2, where ‘a’
is the width and ‘b’ is the length of the horizontal tumor perimeter, determined 3
times a week with a vernier caliper. Five animals were used for each cell type.
The data was analyzed by one-way ANOVA and is represented as mean ±
s.e.m (P< 0.05).
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Hematoxylin/eosin staining: After determination of tumor weight
and/or photography, excised tumors were fixed with paraformaldehyde (4%, 18
h, 4°C) and post-fixed (70% ethanol, 16 h) before dehydration and paraffin
embedding. Paraffin sections were stained with hematoxylin/eosin according to
standard protocols.
Immunohistochemistry: Excised tissues were fixed in formalin and
embedded with paraffin. For IHC, tissue sections were deparaffinized and
rehydrated sequentially through to distilled water (dH2O) before being
immersed in 0.5% hydrogen peroxide/methanol for 10 min. Subsequently,
antigen retrieval was performed with citrate buffer, (pH 6.0) followed by two
changes with dH2O. The sections were subsequently blocked and incubated
with primary antibody (-E-Cadherin: 1: 200; -Vimentin: 1:200; -ILEI: 1:100)
for 1.5 h at 25 0C. The sections were then washed three times with PBS, 5
minutes each, before being incubated with biotinylated secondary antibody for
30 min at 25 0C. The sections were again washed with PBS and then incubated
with Avidin-HRP complex for 30 min at 25 0C. The stain was developed with
diaminobenzidine tetrahydrochloride (DAB) chromogen and observed under
Leica DM 2000 microscope with a 10X or 40X objective lens.
Preparation of single cell suspensions from excised tumors:
Excised tumors were washed with PBS, and sliced manually with a razor blade.
The tissue was then placed in DMEM-F12 media supplemented with 2% calf
serum, 10 g/ml insulin, 100 g/ml penicillin/streptomycin, and 3 mg/ml
collagenase A (Roche) at 370C for 2 h. The resultant disaggregate was
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resuspended in 0.25% trypsin-EDTA for 10 min before being filtered through a
70-m strainer, and plated on tissue culture dishes.
In Vivo luciferase assay: In vivo luciferase assay was performed as
described previously (Chaudhury et al., 2010). In brief, cells were stably
transfected with a constitutively expressed luciferase construct. Luciferase
activity was determined by the Dual Luciferase Reporter assay system
(Promega).
Bioluminescent imaging: For the intravenous model, 1 x 105 cells in
100l PBS were injected into the tail vein of 6-week old BalbC athymic nude
mice (nu/nu). Mice were injected with D-luciferin, anesthetized with isoflurane,
and imaged with an IVIS Imaging System (Xenogen) 10 min. after luciferin
injection. Bioluminescence values at 30 days were compared across the 4
groups.
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CHAPTER III
ESTABLISHMENT OF A TGF-INDUCED EMT GENE SIGNATURE2

3.1 Abstract
A major challenge in the clinical management of human cancers is to
accurately stratify patients according to risk and likelihood of a favorable
response. Stratification is confounded by significant phenotypic heterogeneity in
some tumor types, often without obvious criteria for subdivision. Despite
intensive transcriptional array analyses, the identity and validation of cancer
specific ‘signature genes’ remains elusive, partially because the transcriptome
does not mirror the proteome. The simplification associated with transcriptomic
profiling does not take into consideration changes in the relative expression
among transcripts that arise due to post-transcriptional regulatory events. We
have previously shown that TGF post-transcriptionally regulates epithelialmesenchymal transition (EMT) by causing increased expression of two
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transcripts, Dab2 and ILEI, by modulating hnRNP E1 phosphorylation. Using a
genome-wide combinatorial approach involving expression profiling and RIPChip analysis, we have identified a cohort of translationally regulated mRNAs
that are induced during TGFβ-mediated EMT. Coordinated translational
regulation by hnRNP E1 constitutes a post-transcriptional regulon inhibiting the
expression of related EMT genes, thus enabling the cell to rapidly and
coordinately regulate multiple EMT-facilitating genes.
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3.2 Introduction
Traditional gain-of-function and loss-of-function approaches have yielded
an enormous amount of information in regards to gene function in mammalian
development and disease. However, changes in mRNA levels are not always
correlative with changes in protein abundance, underlying the importance of
post-transcriptional regulation during control of gene expression and activity
(Moore, 2005). Indeed, during germ cell development, it has been demonstrated
that the 3’-untranslated regions (3’-UTR), when fused to a reporter, are sufficient
to confer temporo-spatial specificity for 80% of genes tested (Merrit et al., 2008).
Thus, it is clear that the UTRs of mRNA transcripts can significantly impact gene
expression. The ‘human genome project’ reported the mean lengths of 5’untranslated regions (5’-UTRs) and 3’-UTRs of human mRNAs as 300nt and
770nt, respectively, compared to the mean coding length of 1340nt (Reimann et
al., 2002; International Human Genome Sequencing Consortium, 2001),
generating renewed interest in the 3’-UTRs of mRNAs to map post-transcriptional
regulatory activities.
The epithelial-mesenchymal transition (EMT), in which cells undergo a
developmental switch from a polarized, epithelial phenotype to a highly motile
fibroblastic or mesenchymal phenotype, has emerged not only as a fundamental
process during normal embryonic development and in adult tissue homeostasis,
but is also aberrantly activated during metastatic progression (Derynk et al.,
2001; Zavadil and Bottinger, 2005; Thiery and Sleeman 2006). EMT is
associated with changes in cell-cell adhesion, remodeling of extracellular matrix,
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and enhanced migratory activity, all properties that enable tumor cells to
metastasize (Derynk et al., 2001; Zavadil and Bottinger, 2005; Thiery and
Sleeman 2006). Numerous cytokines and autocrine growth factors, including
TGF, have been implicated in EMT (Bierie and Moses, 2006; Massague, 2008).
Our previous studies (Chaudhury et al., 2010; Hussey at el., 2011) and those of
others (Waerner et al., 2006; Wang et al., 2010) have shown that regulation of
gene expression at the post-transcriptional level plays an indispensable role
during TGF-induced EMT and metastasis. We identified a transcript-selective
translational regulatory pathway in which a ribonucleoprotein (mRNP) complex,
consisting of heterogeneous nuclear ribonucleoprotein E1 (hnRNP E1) and
eukaryotic elongation factor 1A1 (eEF1A1), binds to a 3’-UTR regulatory BAT
(TGFβ activated translation) element and silences translation of Dab2 and ILEI
mRNAs, two transcripts which are involved in mediating EMT (Chaudhury et al.,
2010; Hussey at el., 2011). TGF activates a kinase cascade terminating in the
phosphorylation of hnRNP E1, by isoform-specific stimulation of protein kinase
B/Akt2, inducing the release of the mRNP complex from the 3’-UTR element,
resulting in the reversal of translational silencing and increased expression of
Dab2 and ILEI transcripts.
We have previously shown that shRNA-mediated silencing of Dab2 and
ILEI in normal murine mammary gland (NMuMG) cells is sufficient to inhibit
TGF-mediated EMT as analyzed morphologically and by loss of upregulation of
N-cadherin

and

vimentin,

mesenchymal

cell

markers,

whereas

their

overexpression does not induce constitutive EMT, independent of TGFβ
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signaling (Chaudhury et al., 2010; Prunier and Howe, 2005). Thus Dab2 and ILEI
are required, but not sufficient, for TGFβ-induced EMT. Hence, we, and others
based on our studies (Evdokimova, 2012), hypothesized that there are other
mRNAs that are being silenced by hnRNP E1 in a similar fashion, and which
cumulatively contribute to TGFβ-induced EMT. To address this hypothesis, we
adopted a combinatorial approach involving polysome profiling and RIP-Chip
analyses using hnRNP E1 and filtered the array data based on the regulatory
mechanism of Dab2 and ILEI. This led to the identification and validation of a
cohort of target mRNAs that follow the same pattern of regulation as Dab2 and
ILEI. Similar to Dab2 and ILEI, the identified target mRNAs harbor a structural
BAT element in the 3’-UTR as revealed by in silico analysis. This cohort of
mRNAs may represent a new TGFβ responsive and hnRNP E1-mediated
regulon, operative at a post-transcriptional level in order to mediate TGFβinduced EMT in a temporal and expedited fashion.
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3.3 Results
Experimental

design

and

identification

of

a

TGF-induced

post-

transcriptional EMT gene signature.
To identify potential target mRNA transcripts that are translationally
regulated by hnRNP E1 in a TGF-dependent manner, we adopted a
combinatorial approach involving expression profiling analyses and RNA
immunoprecipitation analysis (RIP-Chip). As shown (Figure

3.1 A), we

performed a screen using: 1) total mRNA and 2) RNA isolated from monosomal
(non-translating) versus polysomal (translating) fractions from TGF-treated (24
h) and non-treated NMuMG cells and from the hnRNP E1 knockdown derivative
(E1KD), that undergo constitutive EMT even in the absence of TGF (Chaudhury
et al., 2010; Hussey at el., 2011). In addition, we screened for transcripts that
selectively interact with hnRNP E1 in NMuMG cells under unstimulated
conditions and subsequently lose their temporal association following TGF
stimulation (Figure 3.1 A). The samples were individually hybridized to Affymetrix
GeneChip® Mouse Genome 430 2.0 arrays.
Following normalization, data was filtered to produce three datasets
representing 1) TGFtranslationally regulated genes, 2) genes translationally
activated following hnRNP E1 knockdown and 3) hnRNP E1 interacting
transcripts (Figure 3.2 B). Genes from the TGFtranslationally regulated dataset
were selected as transcripts that displayed an enhanced ratio of association with
the actively translating polysomal pool compared to the non-translating
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monosomal pool, with no or minor changes in total mRNA expression in NMuMG
cells following TGF stimulation. mRNA transcripts that displayed enhanced
association with polyribosomes irrespective of TGF-treatment in E1KD cells
were candidates for translationally active genes in an hnRNP E1 knockdown
context. Whereas, transcripts which displayed a decreased association with
hnRNP E1 in NMuMG cells following TGF stimulation, as determined by RIPChip analysis, were selected as hnRNP E1 interacting candidates (Figure 3.2 B).
To perform a functional interpretation of our array analysis, all three
datasets were queried against GO, Panther and KEGG databases using DAVID
and Panther platforms (Table 3.1). Analysis of the TGF translationally regulated
dataset revealed significant enrichment of categories associated with cell cycle,
transcription and ubiquitin-mediated proteolysis. Genes actively translated in
E1KD cells are involved in cell cycle, translation and the regulation of the actin
cytoskeleton, whereas, transcripts that displayed differential interaction with
hnRNP E1 mapped to terms associated with transcription, ubiquitin-mediated
proteolysis, in addition to enrichment of several signaling pathways including
MAPK, Wnt, integrin and Ras pathway. This analysis is consistent with our
findings that TGF-mediated translational regulation plays a major role during
EMT (Chaudhury et al., 2010; Hussey at el., 2011), as evidenced by enrichment
of EMT-associated processes and pathways. In addition, our data indicates that
EMT-associated processes are coordinately regulated at both the transcriptional
and post-transcriptional level. Enrichment of EMT-associated pathways within the

63

E1KD and RIP datasets also suggest that hnRNP E1 is a key effector of TGFmediated translational regulation.
Identification of candidate mRNA transcripts translationally regulated by
hnRNP E1 in a TGF-dependent manner.
In order to identify genes whose expression is translationally regulated by
TGF through hnRNP E1, the intersection of our three data sets was utilized
(Figure 3.1 B) revealing 36 genes, which we have termed BAT genes (Table 3.2).
The translational status of the 36 putative BAT genes as determined by isolation
of non-translating monosomal (M) fractions (40S, 60S and 80S) and actively
translating polysomal (P) fractions from cells treated ± TGFβ for 24 h (Figure 3.2
A) is represented by the signal intensities of monosomal and polysomal
association, and is displayed as a heat plot (Figure 3.2 B). The data reveal that
the expression of these transcripts (total mRNA) did not vary significantly ± TGF
in either the parental NMuMG or E1KD cells (Figure 3.2 B). However, in the
NMuMG cells, these transcripts preferentially translocated from the M to P
fractions following TGF stimulation, whereas in the E1KD cells, these transcripts
were associated with the P fraction irrespective of TGF-treatment (Figure 3.2
B). This methodology accurately identified ILEI as one of the target transcripts,
as demonstrated by semi-quantitative RT-PCR analysis of the sample cDNA
used for the microarray hybridization (Figure 3.2 C). The ILEI mRNA is
polyribosome-associated following TGF-treatment in parental NMuMG cells,
whereas it is found polyribosome-associated in the E1KD cells in the absence or
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presence of TGF. Total ILEI mRNA levels were not affected by TGF
stimulation in either cell type (Figure 3.2 C).
Interestingly, several of the identified mRNAs have been previously
implicated as targeted transcripts of TGF-mediated translational regulation
including calpastatin (Barnoy et al., 2000) and epidermal growth factor receptor
(Wendt et al., 2010). Additionally, this approach identified several candidates that
have been shown to be involved in the EMT process including Eukaryotic
initiation factor 5A2 (Zhu et al., 2012), Moesin (Wang et al., 2012), Egfr (Lo et al.,
2007) and Inhibin beta-A (Yoshinaga et al., 2004). The data demonstrate, that
similar to ILEI, TGF induces translocation of these mRNAs from the M to P
fractions in the parental NMuMG cells, and that in the E1KD cells these mRNAs
are associated with the P fractions irrespective of TGF treatment (Figure 3.2 B).
These candidates were subsequently used for further validation studies.
Validation of selected genes from the Affymetrix Array.
We next addressed whether the translational regulation of polysomebound transcripts correlated with respective RNA and protein levels. Initially, we
performed a polysome profile expression analysis independent of the pooled
microarray samples to further demonstrate the translocation of mRNA from the
non-translating M fractions to the actively translating P fractions in non-stimulated
and TGF-treated cells. In parental NMuMG cells, the target mRNAs are
primarily associated with the 80S fraction in non-stimulated cells, and display a
complete shift to the actively translating polysomes after 24 h of TGF treatment
(Figure 3.3 A). These results are in agreement with our previous findings that
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hnRNP E1-directed translational regulation targets the 80S stage of translation
elongation (Hussey at el., 2011). In contrast, the hnRNP E1 knockdown E1KD
cells displayed abundant target mRNA in the actively translating polysomal
fractions irrespective of TGF treatment (Figure 3.3 B). As a control, semiquantitative RT-PCR with -actin specific primers displayed continuous
association of the mRNA with the polysomes irrespective of TGF-treatment
(Figure 3.3 A, B), demonstrating that the translational control is transcript-specific
and not due to global regulation of translation.
We next investigated the temporal relationship between total mRNA levels
and protein expression levels in TGF-treated NMuMG and E1KD cells. With the
exception of moesin, total mRNA levels for these target genes, as measured by
quantitative real time PCR (qPCR), displayed only minor changes following
TGF-treatment in both the NMuMG and E1KD cells compared to a ~5 fold
increase in Fibronectin (Fn1), a mesenchymal marker and target of TGFmediated transcriptional regulation (Figure 3.3 C, D). These results concur with
the microarray data that demonstrate that total mRNA levels for these transcripts
were only slightly induced by TGF (Figure 3.2). However, it cannot be
completely excluded from these results that transcriptional regulation is involved,
albeit at a low rate. In contrast, protein expression levels, as analyzed by
immunoblot analysis (Figure 3.3 E), revealed that non-stimulated NMuMG cells,
despite having abundant message, have low levels of protein for these target
genes, and display a rapid, and time-dependent increase in protein expression
levels following TGF-treatment (Figure 3.3 E). Furthermore, the increased
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protein expression levels of these transcripts were shown to correlate with
acquisition of a mesenchymal phenotype as demonstrated by increased
expression of the mesenchymal marker N-cadherin and decreased expression of
Zona occludens 1 (ZO-1). In contrast, in the E1KD cells, although there is not an
apparent reduction in the expression of epithelial cell marker ZO-1,

the

expression of the mesenchymal marker N-cadherin, as well as the protein
expression levels of the the BAT genes, were constitutive irrespective of TGFtreatment (Fig. 3E).
Target mRNAs are regulated through interaction with hnRNP E1 and a
structurally conserved BAT element.
According to the RIP-Chip data, the selected target genes displayed a
decrease in association with hnRNP E1 following TGF-treatment. The average
signal intensity of the association with hnRNP E1 between control and TGFtreated samples are represented as a heat plot (Figure 3.4 A). In each case, less
of these mRNAs were immunoprecipitated by -hnRNP E1 in the presence of
TGF compared to the control, unstimulated NMuMG cells (Figure 3.4 A). To
further investigate the temporal association of hnRNP E1 with the selected target
genes, we performed a RIP analysis independent of the microarray samples. As
shown (Figure 3.4 B), hnRNP E1 interacts with the target transcripts.
Immunoprecipitation with -hnRNP E1 or mouse IgG from cytosolic extracts
prepared from NMuMG cells treated with TGF for the times indicated, followed
by RT-PCR analyses, revealed that while target mRNAs were steadily
expressed, hnRNP E1 interaction occurred primarily in non-stimulated cells.
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These results are in agreement with our previous findings that TGF activates a
kinase cascade terminating in the phosphorylation of hnRNP E1, by isoformspecific stimulation of protein kinase B/Akt2, inducing the release of the hnRNP
E1 from the 3’-UTR cis regulatory element, resulting in the reversal of
translational silencing and increased expression of EMT-facilitating transcripts
(Chaudhury et al., 2010).
We have previously identified the structural BAT element in the 3’-UTRs of
Dab2 and ILEI which binds hnRNP E1 and mediates TGFβ-induced translational
regulation of these transcripts (Chaudhury et al., 2010). The Dab2 and ILEI BAT
elements consist of a proximal stem and an asymmetric bulge followed by a
distal stem and terminal loop (Figure 3.4 C). In order to determine whether the
selected target genes also contain a respective BAT element, we utilized a
consensus BAT element pattern, based on the secondary structure of Dab2 and
ILEI BAT elements, to query the non-redundant 3’UTR sequences of the selected
target genes using RNAmotif, an RNA secondary structure algorithm (Macke et
al., 2001). Putative BAT elements were identified in the target mRNAs with
significant folding similarity as identified by the stem-loop and asymmetric bulge
(Figure 3.4 D, E).
We next examined the temporal association of hnRNP E1 with the
predicted BAT elements using an RNA affinity pull down assay (Figure 3.4 F).
The respective BAT element cRNAs were coupled to sepharose beads, and
used to precipitate hnRNP E1 from cytosolic S100 extracts isolated from TGFtreated and non-treated NMuMG cells. As a negative control, we used the

68

Dab2/U10A element (BAT-M), which contains a U to A substitution at position
10 which unfolds the stem loop structure resulting in diminished binding affinity
to hnRNP E1 (Chaudhury et al., 2010; Hussey at el., 2011). Immunoblot
analysis confirmed that hnRNP E1 was precipitated by the predicted Egfr and
Eif5a2 BAT elements from non-stimulated NMuMG, but TGF treatment
induced the loss of hnRNP E1 binding in a time-dependent manner.
Additionally, pre-treatment of NMuMG cells with the PI3K inhibitor LY294002,
blocked the ability of TGF to modulate hnRNP E1 interactions (Figure 3.4 F),
consistent with our previous observation that inhibition of the PI3K/Akt pathway
blocked hnRNP E1 Ser43 phosphorylation (Chaudhury et al., 2010).
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Figure 3.1: Illustration of experimental design. (A) Flow chart representing the experimental
design. For expression profiling, cytosolic extracts from untreated and TGFβ-treated (24 hr)
NMuMG and E1KD cells were fractionated by sucrose gradient centrifugation and RNA was
isolated from the non-translating monosomal pool and actively translating polysomal pool,
designated as M and P, respectively (n=2). Total unfractionated RNA was isolated from NMuMG
and E1KD cells treated ± TGF (24 hr) (n=2). For the RIP-Chip analysis, cytosolic extracts from
untreated and TGFβ-treated (24 hr) NMuMG cells were immunoprecipitated with α-hnRNP E1
antibody or an isotype control (n=2). (B) Venn diagram summarizing the results of the genome
wide analysis. Intersection of the three data sets yielded 36 putative BAT genes whose
expression is translationally regulated by TGF through hnRNP E1.
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Figure 3.2: Quantitative representation of data. (A) Schematic of polysome profile analysis.
Monosomal fractions (M; 40S, 60S, and 80S fractions) and polysomal fractions (P) from NMuMG
or E1KD cells treated ± TGFβ for 24 hr were isolated by sucrose gradient centrifugation and
pooled. (B) Heatmap of the raw signal intensity values of the differential gene expression profile
for the EMT signature genes compared to total, unfractionated mRNA. Lane 1: NMuMG (M) 0h,
2:NMuMG (P) 24h, 3:(C) RT-PCR analysis of microarray RNA samples was used to demonstrate
the differential gene expression profile of ILEI.
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Figure 3.3: Validation of the putative EMT signature gene targets. (A and B) RT-PCR
analysis using gene specific primers for the potential targets and β-Actin (control) on a polysome
profile of NMuMG and E1KD cells ± TGFβ for 24 hr. (C and D) Total RNA was isolated from
NMuMG and E1KD cells treated with TGF for the indicated times and subjected to qPCR
analysis to assess steady state mRNA expression levels. Data are presented as means ± s.e.,
n=3 (*P > 0.05) (E) Immunoblot analysis examining protein expression levels of the potential
targets, -Hsp90 (control) and -N-cadherin and -ZO-1 (EMT markers), in NMuMG and E1KD
cells treated with TGF for the indicated times.
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Figure 3.4: Identified mRNAs contain the BAT element and exhibit differential binding to
hnRNP E1. (A) Heatmap of the RIP-Chip analysis for the putative EMT signature genes. (B)
NMuMG cells were treated with TGFβ for times indicated, and RT-PCR was performed using
gene specific primers for the potential targets, β-Actin (control) and Snail (EMT marker), on a RIP
analysis. (C) Dab2/BAT and ILEI/BAT structures. Specific regions of the BAT element were
selected and used to query the 3’-UTRs of the target mRNAs. (D and E) Secondary structures
and sequences of target mRNAs with similarities to Dab2/BAT. (F) RNA affinity pull-down and
immunoblot analyses to define the temporal association of hnRNP E1 with the selected BAT
elements.
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Process/Pathway

Database

number of genes
mapped to term
(expected number)

Pvalue

GO biological process
GO biological process
Panther biological process
GO biological process
Panther biological process
GO biological process
GO biological process
GO biological process
KEGG pathway
GO biological process
KEGG pathway
Panther biological process
Panther pathway
Panther biological process

34 (8.3)
36 (9.5)
140 (87.5)
54 (20.8)
27 (9.0)
101 (59.4)
24 (6.9)
37 (14.8)
16 (4.1)
29 (10.4)
14 (4.0)
21 (8.1)
8 (1.6)
20 (7.7)

1.8 E-08
4.6 E-08
1.6 E-07
5.0 E-07
2.1 E-04
2.4 E-04
5.8 E-04
0.001
0.002
0.003
0.020
0.030
0.043
0.046

Panther biological process
Panther biological process
GO biological process
KEGG pathway

87 (54.4)
33 (15.7)
20 (6.7)
14 (4.5)

8.4 E-04
0.014
0.046
0.055

GO biological process
GO biological process
KEGG pathway
Panther biological process
GO biological process
Panther biological process
KEGG pathway
Panther pathway
Panther biological process
KEGG pathway
KEGG pathway
Panther biological process
Panther biological process
Panther pathway
GO biological process
Panther pathway
Panther pathway
Panther pathway
Panther biological process
GO biological process
KEGG pathway
Panther biological process
Panther pathway
KEGG pathway
Panther pathway

268 (187.7)
220 (137.5)
43 (17.9)
101 (59.4)
176 (117.3)
103 (64.4)
26 (9.3)
35 (14.6)
178 (127.1)
44 (22)
19 (5.9)
77 (48.1)
276 (230)
13 (3.3)
76 (44.7)
17 (5.6)
20 (7.5)
12 (3.2)
115 (82.1)
21 (6.8)
29 (13.8)
36 (18)
21 (8.4)
21 (8.4)
17 (6.3)

1.6 E-10
3.3 E-09
2.6 E-05
3.2 E-05
4.9 E-05
3.5 E-04
6.6 E-04
6.0 E-04
0.001
0.002
0.002
0.004
0.004
0.006
0.008
0.013
0.018
0.022
0.023
0.026
0.026
0.029
0.029
0.032
0.049

TGF regulated dataset
Mitotic cell cycle
Cell division
Nucleoside, nucleotide and nucleic acid metabolism
Cell cycle
Mitosis
Transcription
RNA splicing
RNA processing
Cell cycle
mRNA metabolic process
Spliceosome
DNA metabolism
Ubiquitin proteasome pathway
Pre-mRNA processing

hnRNP E1 knockdown dataset
Nucleoside, nucleotide and nucleic acid metabolism
Cell cycle
Translation
Regulation of actin cytoskeleton

hnRNP E1 RIP dataset
Regulation of transcription
Transcription
MAPK signaling pathway
Intracellular signaling cascade
Regulation of RNA metabolic process
Intracellular protein traffic
Ubiquitin mediated proteolysis
Wnt signaling pathway
mRNA transcription
Pathways in cancer
Colorectal cancer
Protein phosphorylation
Nucleoside, nucleotide and nucleic acid metabolism
B cell activation
Protein catabolic process
EGF receptor signaling pathway
Angiogenesis
Ras Pathway
Protein modification
Regulation of Rho protein signal transduction
Focal adhesion
Endocytosis
Integrin signalling pathway
Natural killer cell mediated cytotoxicity
PDGF signaling pathway

Table 3.1: Number of genes from dataset assigned to a given biological process or pathway is
compared to the number of genes expected by chance to map to the term. P-value adjusted for
multiple testing using the Bonferroni method.
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Accession

Gene Name

Fold
Change
Total
mRNA in
NMuMG

BM232998
NM_015753
U03425
BC003232
W30094
AU067741
NM_008413
BB221842
AV357135
BE943736
AK012196
BI662324
AV271901
BC004850
BG071905
X58380
AV174556
AK010212
BC025048
BQ174163
NM_020296
AF065933
BF383782
BC027138
NM_008380
NM_010833
BB148748
BM213828
AV127581
BF119821
NM_011544
AW825881
AK017688
BB268102
AF100171
AK016470

2810474O19Rik
Zeb2
Egfr
Actn1
0610010F05Rik
D3Ertd254e
Jak2
Sh3glb1
Baz1a
Asap1
Pip4k2a
Gna13
Eif5a2
Twsg1
Palld
Hmga2
Ubxn2a
Pkia
Dusp7
Tmem167
Rbms1
Ccl2
Tmem65
Zbtb44
Inhba
Msn
Cast
Kpna3
2700049H19Rik
Dpp8
Tcf12
Zfp266
5730469M10Rik
Phf20l1
Mlf1
Fam3c

1.6934906
1.8087588
1.0139595
1.5691682
1.6021398
1.1850928
1.7592982
1.1526863
1.0174797
1.1289644
1.9520635
1.2184103
1.1289644
1.0867349
1.6132835
0.9106698
1.2397077
1.7592982
1.270151
1.2483305
0.9233823
1.0245568
1.0245568
1.2099941
0.8321987
1.9453099
1.6414832
1.5691682
1.2483305
1.1974787
1.4590203
1.4142136
0.9896567
0.952638
1.547565
1.226885

Fold Induction
Polysomal
mRNA in
NMuMG

Fold Change
Total mRNA
in E1KD

Fold Induction
Polysomal
mRNA in E1KD

Fold
Change
in hnRNP
E1
binding

20.82147
21.33278
5.856343
6.254957
7.568461
11.63178
6.727171
5.540438
14.02569
5.063026
13.17746
7.412704
6.988583
10.59271
9.57983
5.676493
7.621104
13.04116
7.542276
11.27457
6.105037
5.521269
8.845845
5.169411
5.205367
14.22148
11.47164
7.862565
6.988583
8.907373
6.19026
10.37472
8.310873
5.37029
17.44812
7.260153

1.574616
0.600818
0.8066418
1.6529006
1.2570134
1.0245568
1.4339552
1.2834259
1.7411011
1.0717735
1.201636
0.9726549
1
0.9794203
1.69937
1.8986842
1.1566882
1.3472336
1.5422108
1.2789856
0.8705506
1.9185282
1.082975
0.8150723
1.1134216
1.3058598
1.1809927
1.3195079
1.5583292
1.201636
1.082975
1.6643975
1.053361
1.531558
1.9318727
0.9362722

1.8150383
1.5368752
1.4240502
1.3013419
1.0792282
1.6245048
1.2141949
1.3995859
1.4948492
1.4896775
1.7171309
1.866066
1.4590203
1.4948492
1.5583292
1.3613141
1.9453099
1.771535
1.5583292
1.6021398
1.7532114
1.0069556
1.6934906
1.5052467
1.5800826
1.9930805
1.8150383
1.8403753
1.1769067
1.7290745
1.2397077
1.0606877
1.3707828
1.9793133
1.9656412
2.0849315

1.82134
2.386671
1.464086
1.510473
1.389918
1.552938
1.918528
1.82134
1.399586
1.433955
2
1.574616
1.337928
1.274561
1.735077
1.274561
1.261377
1.36604
2.136131
1.310393
1.30586
1.607702
1.239708
1.29684
1.274561
1.892115
2.034959
1.494849
1.618884
1.252664
1.531558
1.515717
1.22264
1.324089
1.380317
1.185093

Table 3.2: List of 36 potential BAT genes identified by the combinatorial approach. Despite minor
changes in total RNA levels, the target mRNAs display a >5 fold increase in polyribosome
association in NMuMG cells post TGFtreatment compared to E1KD cells where the target
mRNAs display constitutive translational activation. Target mRNAs display a decrease in
temporal association with hnRNP E1 following TGF stimulation for 24 hr.
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3.4 Discussion
Despite intensive transcriptional array analysis of human tumors, the
identity and validation of ‘EMT signature genes’ remains elusive (Pradet-Balade
et al., 2001; van’t Veer et al., 2002; Kang and Massague, 2004), partially
because the transcriptome does not mirror the proteome (van der Kelen et al.,
2009). To understand how the interplay of RNA-binding proteins affects the
regulation of individual transcripts, high-resolution maps of in vivo protein-RNA
interactions are necessary (Keene and Lager, 2005). An alternative approach is
expression profiling on a genome wide scale, whereby non-translating and
actively translating pools of mRNAs are isolated by sucrose density gradient
fractionation and subsequently subjected to microarray analysis (Zong et al.,
1999). RNA-Binding Protein Immunoprecipitation-Microarray (RIP-Chip) profiling
is an advanced high-throughput analysis of mRNAs that co-immunoprecipitate
with particular mRNA-binding proteins (Penalva et al., 2004). An mRNA-binding
protein of interest is immunoprecipitated, and the associated mRNA is isolated
and subsequently subjected to microarray analysis. A combinatorial approach
involving expression profiling and RIP-chip analysis on a genome-wide basis will
yield definitive information on a particular regulatory pathway.
Herein, we have identified a cohort of translationally regulated mRNAs
that are upregulated during TGFβ-induced EMT by using a combinatorial
approach involving polysome profiling and RIP-Chip analysis. Filtering the
Affymetrix array data based on the translational state of transcripts in nonstimulated and TGF-treated NMuMG and E1KD cells, and intersecting these
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genes sets with the RIP-chip analysis led to the identification of a set of target
mRNAs that follow the same pattern of regulation as Dab2 and ILEI, two
transcripts necessary for EMT which were previously shown to be translationally
regulated by TGF through hnRNP E1 (Chaudhury et al., 2010; Hussey et al.,
2011). While our confidence in the establishment of this TGF-induced posttranscriptional EMT signature was strengthened by the identification of several
transcripts which have been previously shown to be translationally regulated by
TGF, including calpastatin (Barnoy et al., 2000) and epidermal growth factor
receptor (Wendt et al., 2010), our approach was not without some limitations. For
example, this approach correctly identified ILEI mRNA, a well-characterized
target for BAT-mediated translational silencing (Chaudhury et al., 2010; Hussey
et al., 2011), however, another previously identified target, Dab2 remained
unidentified. This result may be due to a low signal-to-noise ratio of Dab2
expression levels, as the microarray based approach requires that the level of
expression of target mRNA exceeds the cutoff limit of detection with a highsignal-to noise ratio (vyas et al., 2009).
Protein expression levels depend on the rate of transcription, as well as
other defined control mechanisms, such as mRNA stability (Garcia-Martinez et
al., 2004), nuclear export and mRNA localization (Hieronymus and Silver, 2004),
translational regulation (Beilharz and Preiss, 2004), and protein degradation
(Beyer et al., 2004). Post-transcriptional regulation is mainly controlled by the
association of trans-acting RNA binding proteins with cis-regulatory regions in the
UTRs of mRNAs. The bioinformatic prediction of putative BAT elements in the
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identified BAT mRNAs reveals a conserved structure-based homology based
upon the functional structural motif previously identified for Dab2 and ILEI. These
structures within the 3’-UTRs of the selected target mRNAs all share a stem-loop
motif with an asymmetric bulge, albeit with considerable sequence diversity.
Although the Egfr and Eif5a2 BAT elements were validated for their ability to bind
hnRNP E1, a more comprehensive analysis is still required. This includes, but is
not limited to fine mapping and cloning of the 3’-UTR of the candidate genes into
reporter vectors to demonstrate functional gain-of-silencing potential.
The BAT element provides further insights into the importance of
regulatory elements in the maintenance of homeostasis. Our results are
suggestive of a stimulus-dependent upregulation of a post-transcriptional regulon
coordinated by the concerted action of a trans-acting mRNP complex and a cisregulatory element in the 3’-UTR of target genes. Eukaryotic regulons are
defined as higher-order genetic units (quasi genome) consisting of monocistronic
mRNA subsets under the control of a regulatory RNA binding protein (Keene and
Lager, 2005).

RNA binding proteins have been shown to specifically bind

transcripts encoding functional and colocalized protein classes (Brown et al.,
2001; Waggoner and Liebhaber, 2003; Gerber et al., 2004). Post-transcriptional
regulons may have evolved as a mechanism to rapidly and coordinately
suppress multiple EMT genes.
During the invasive phase of metastasis, a carcinoma cell activates EMT
programs by different regulatory pathways. Differentiation to a mesenchymal
phenotype enables the cancer cell with the ability to survive through the different
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steps of metastatic progression, including localized invasion by primary tumor
cells, intravasation, translocation, extravasation and finally micrometastatic
colonization at the secondary site (Massague, 2008). Now, we demonstrate a
cohort of selective transcripts that are post-transcriptionally upregulated by TGFβ
and are correlative with an induction of the EMT phenotype. Akt2-mediated
hnRNP E1 phosphorylation post-TGFβ stimulation is the regulatory mechanism
mediating

the

TGF-induced

translational

activation

of

EMT-facilitating

transcripts. We have now shown that hnRNP E1 is a central moiety in this
process, and may represent an important molecular target for the development of
modulators of this translational regulatory pathway. Furthermore, the continued
delineation of the role of the identified target transcripts during EMT will prove to
be extremely useful and will allow for their interrogation and manipulation in
physiological and pathological situations.
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3.5 Materials and Methods
Reagents: Mouse -hnRNP E1 and -ZO-1 were obtained from Novus
Biologicals. -ILEI, α-Inhibin beta A and α-EIF5A2 were obtained from Abcam. αEGFR was obtained from Cell Signaling Technology. -Moesin was purchased
from BD Biosciences. -Hsp90 and normal mouse IgG were purchased from
Santa Cruz Biotechnology. Secondary antibodies, -mouse and -rabbit-IgGHRP were obtained from GE Healthcare Bio-Sciences. Refer to Table 1 for
primer sequences.
Cell culture and treatments. NMuMGs were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum, 10 mg/ml
insulin, and antibiotics/antimycotics (100 units/ml penicillin G, 100 mg/ml
streptomycin, and 0.25 mg/ml amphotericin B). E1KD (previously termed SH14)
were generated in the laboratory and have been described (Chaudhury et al.,
2010). TGF2 was a generous gift from Genzyme Inc. and was used at a final
concentration of 5 ng/ml. Where indicated, cells were treated with 10 M of
LY294002 30 min before TGF treatment.
RNA immunoprecipitation: RNA immunoprecipitation was performed as
described previously (Penalva et al., 2004). Briefly, the cytosolic extract was
incubated with 10 μg of mouse α-hnRNP E1 antibody or mouse α-IgG at 4°C
overnight, and precipitated with Protein A-Sepharose (Invitrogen). The beads
were washed three times with IP Wash Solution (150 mM NaCl, 50 mM Tris pH
7.5, 0.5% NP40), and immunoprecipitated RNAs isolated by Trizol (Invitrogen)
and treated with RNase-free DNase I (Applied Biosystems).
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Polysome profiling: Polysome analysis was performed as described
previously (Merrick and Hensold, 2001). Briefly, cell lysates were layered onto a
10%-50% sucrose gradient and centrifuged at 100,000 x g at 4 0C for 4 h.
Gradient fractions were collected using a fraction collector with continuous
monitoring of absorbance at 254 nm. RNA was extracted with Trizol (Invitrogen)
and purified with RNeasy minikit (Qiagen).
Microarray data processing: Affymetrix microarray analysis was
conducted on two independent samples for each experimental condition.
Samples

were

processed

at

the

MUSC

Proteogenomics

Facility

(http://proteogenomics.musc.edu) using Affymetrix Mouse Genome 430 2.0
GeneChips® in accordance with the manufacturer protocols. The resulting raw
data files were deposited in the NCBI Gene Expression Omnibus (Accession
#GSE20152). Hybridization data (CEL files) were normalized by RMA algorithm
using Affymetrix Expression Console software; detection calls were obtained by
Affymetrix MAS5 algorithm. Gene representations not receiving ‘present’
detection scores in ≥25% of all samples were excluded from further analysis.
Data analysis: The average raw signal intensity values from two
independent samples for each experimental condition were determined and used
for multiparametric comparisons. Filtering of the genes sets met the following
criteria: i) the ratio of the average raw signal intensity of monosomal (M) versus
polysomal (P) mRNAs from control NMuMG cells was filtered as (Mcontrol/Pcontrol ≥
2), whereas in the E1KD cells the parameter was set at (P control/Mcontrol ≥ 2); ii) the
ratio of P vs. M associated mRNAs from TGF-treated NMuMG and E1KD cells
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was filtered as (PTGF/MTGF ≥ 2); iii) fold change in total RNA from control vs.
TGF-treated cells was determined by (Total RNA

/Total RNAcontrol ≤ 2); and,
-

stimulation compared to control was filtered at ([(PTGF/MTGF)/(Pcontrol/Mcontrol)] ≥
5),

whereas

in

the

E1KD

cells

the

parameter

was

set

at

([(PTGF/MTGF)/(Pcontrol/Mcontrol) < 2). Finally, for the RIP-Chip, the ratio of the
average raw signal intensity for mRNAs immunoprecipitated by hnRNP E1 in
control NMuMG cells vs. TGF-treated was filtered at (IP:E1 Control/TGF ≥
1.2), whereas for the IgG immunoprecipitation the parameter was set at (IP:IgG
Control/TGF ≤ 1).
Real-time quantitative PCR (Taqman system): Total RNA was isolated
by Trizol extraction. Reverse transcription was performed using the Superscript
first strand synthesis system (Invitrogen). Quantitative PCR was performed using
an Applied Biosystems 7500 Fast Real-Time PCR System and default cycle
conditions. Briefly, reactions were prepared using 50ng cDNA, Taqman® Fast
Universal PCR Master Mix and mouse-specific primers for Egfr (cat number
Mm00433023_m1), Moesin (Mm00447889_m1), Eif5a2 (Mm00812570_g1),
Fam3c (Mm00506842_m1), Inhba (Mm00434339_m1), Fn1 (Mm01256744_m1),
and Gapdh (Mm99999915_g1) according to manufacturer's protocol (Life
technologies). All samples were run in triplicate and normalized to Gapdh. Data
analysis was performed using the relative quantification (CT) method (Livak
and Schmittgen, 2001).
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Preparation of cytosolic extract (S100 Fraction): S100 fractions were
prepared from cells as previously described (Mazumder and Fox, 1999) with
minor modifications. Briefly, the buffer used for cytosolic extraction contained 20
mM Hepes (pH 7.5), 10 mM KCl, 1.5 mM MgCl2, 1 mM EGTA, 1 mM EDTA, 1
mM DTT and protease inhibitor cocktail (Roche).
RNA pulldown: RiboMax kit (Promega) was used to generate milligram
quantity of BAT cRNA. cRNA was bound to CNBr-activated Sepharose beads
and incubated for 1 h at 4 0C with 50 g of cytosolic extract (S100 Fraction) from
NMuMG cells treated ± TGF. Following incubation, beads were washed with 0.2
M NaCl and resolved by SDS-PAGE.
Functional

pathway

search

analysis:

Functional

analysis

was

performed using the Database for Annotation, Visualization and Integrated
Discovery (DAVID), Molecular Signature Database (MSigDB) and Protein
Analysis Through Evolutionary Relationships (Panther) platforms. Biological
processes and pathway terms from Gene ontology (GO), Kyoto Encyclopedia of
Genes and Genomes (KEGG), Panther, Reactome and Biocarta databases were
utilized.
Bioinformatic prediction of BAT elements: Analysis of select 3’UTR
genes was completed using RNAmotif software (Macke et al., 2001) on a
MacBook Pro using an Intel Core-i7, 4gb of RAM, and Mac OS-X 10.6. Software
was compiled using GNU’s GCC compiler (gcc.gnu.org) in the OS-X terminal
utility. Descriptor file was written using Xcode version 3.2 in the C development
module. Input file was created in a generic text editor, sequences were obtained
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from UTRdb (utrdb.ba.itb.cnr.it). Analysis was run from the OS-X terminal utility,
output was sent to a generic text file to be used for later interpretation.
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CHAPTER IV
FUTURE PERSPECTIVES:
BAT-MEDIATED EMT AND CANCER STEM CELLS

4.1 Abstract
We have identified a TGF-regulated mRNP complex containing the RNAbinding protein hnRNP-E1 which inhibits the translation of genes essential for
EMT by blocking eEF1A1 release during translation elongation. Phosphorylation
of hnRNP-E1 in response to TGFβ signaling disrupts the hnRNP E1-eEF1A1
interaction, triggering EMT. While many types of cancer cells leaving primary
tumors rely on an EMT program to facilitate the initial steps of the invasionmetastasis process, how an EMT program promotes their self-renewal capability
is not completed understood. This can in part be addressed by the recent
discovery that induction of EMT can stimulate cultured breast cells to adopt
characteristics of stem cells including competence of self-renewal and capacity to
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differentiate. Herein, we provide evidence that attenuation of the BAT-mRNP
complex in normal mammary gland epithelial cells can mediate acquisition of a
stem-like phenotype. As an in vitro test of mammary gland stem cell function we
demonstrate that modulation of hnRNP E1 allowed these cells to effectively grow
in mammosphere culture. Furthermore, we demonstrate that this induced EMT in
normal mammary gland epithelial cells was able to reconstitute a differentiated
mammary gland following implantation into cleared fat pads. These results
provide evidence for the requirement of TGF-mediated translational activation of
EMT-inducer transcripts for facilitating the reprogramming of epithelial cells and
to promote their self-renewal capability.
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4.2 Introduction
Human carcinomas exhibit a wide range of signaling events to promote
migration and invasion. It has become evident that cancer cells can
dedifferentiate through activation of specific biological pathways associated with
epithelial-mesenchmal transition (EMT), gaining the ability to migrate and invade
(Brabletz et al., 2005). Thus, EMT has emerged not only as a fundamental
process during normal embryonic development and in adult tissue homeostasis,
but has also been demonstrated to be essential for metastatic progression
(Derynck et al., 2001; Thiery and Sleeman, 2006; Zavadil and Bottinger, 2005)
Recent reports have suggested that epithelial cells that pass through an
EMT acquire a stem cell-like phenotype associated with cancer stem cells (Mani
et al., 2008; Morel et al., 2008). It is postulated that many cancers, including
breast cancer, are driven by a population of cancer stem cells that display stem
cell-like characteristics (Al-Hajj et al., 2003; O’Brien et al., 2007; Ricci-Vitianiet
al., 2007; Singh et al., 2004). Cancer stem cells isolated from mammary gland
tumors are characterized by their highly tumorigenic potential, their self-renewal
capacity, potential for multilineage differentiation, and the ability to generate
suspended spherical colonies (mammospheres) when cultured in serum-free
medium in non-adherent conditions (Mani et al., 2007). Several cell surface
markers have been reported to identify mammary stem cells. For example, a
subpopulation of mammary gland stem cells isolated from humor tumors have
been shown to express an antigenic phenotype in the CD44hi/CD24low
configuration (Al-Hajj et al., 2003; Mani, 2008), whereas enrichment of a
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population of mammary gland cells from mice exhibit a CD29hi/CD24+ pattern
(Mani et al., 2007; Visvader and Lindeman, 2006; Wang 2006). Despite recent
advances in our understanding of cancer stem cells, the signaling mechanisms
that induce and maintain the EMT and stem cell state are not completely
understood.
We have described a transcript-selective translational regulatory pathway
in which a ribonucleoprotein (mRNP) complex, consisting of heterogeneous
nuclear ribonucleoprotein E1 (hnRNP E1) and eukaryotic elogation factor 1-A1,
binds to a 3´-UTR regulatory TGF--activated translation (BAT) element and
silences translation of a cohort of EMT-facilitating transcripts. TGF- activates a
kinase cascade terminating in the phosphorylation of hnRNP E1 by isoform-specific stimulation of protein kinase B/Akt2, which induces the release of the mRNP
complex from the 3´-UTR element, resulting in the reversal of translational
silencing and increased expression of EMT-facilitating transcripts. In a
translational-state microarray analysis, in which differential sedimentation is used
to separate the nontranslating, nonpolysomal pool of transcripts from the actively
translating, polysome-associated transcripts, Interleukin-like EMT Inducer (ILEI)
was demonstrated to be translationally upregulated during EMT.
ILEI (previously termed Fam3C) is a member of a recently discovered
gene family (Fam3A-D), which was identified using structure-based methods to
search for four-helix-bundle cytokines (Zhu et al., 2002). Functionally, ILEI has
been demonstrated to be involved in the contribution of EMT. For example,
stable overexpression of ILEI in mammary epithelial cells has been reported to
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be sufficient to promote EMT and enhance tumor growth and lung metastasis
upon teil vein injection (Wearner et al., 2006). Although there has been little
progress in the analysis of ILEI-dependent signal transduction or identification of
the receptor, a recent report has suggested that overexpression of

ILEI in

hepatocytes is associated with nuclear accumulation of phosphorylated STAT3
(Lahsnig et al., 2009). As a downstream signaling molecule, STAT3 has been
shown to be involved in a variety of tumor related functions including
proliferation, embryonic cell-renewal, EMT and migration (Niwa et al, 1998;
Yamashita et al., 2002).
We have demonstrated that normal mammary epithelial cells which have
undergone an EMT in response to modulation of hnRNP E1 expression levels
(E1KD cells), and thus modulation of the BAT mRNP complex, acquire an
inherent tumorigenic and metastatic capacity concomitant with increased ILEI
expression. Given the highly tumorigenic nature of E1KD cells, we decided to
address the association between BAT-mediated EMT and the stem-like
phenotype. We show that E1KD cells acquire the ability to form mammospheres
in vitro, and have the ability to regenerate cleared mammary fat pads in mice.
Furthermore, we provide evidence suggesting that acquisition of the stem-like
phenotype may be mediated by establishment of ILEI paracrine loops and
activation of downstream STAT3 signaling.
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4.3 Results
Modulation of hnRNP E1 expression in normal mammary gland epithelial
cells mediates stem-like characteristics.
To determine whether modulation of hnRNP E1 expression in normal
mammary epithelial cells can mediate stem-cell like traits in addition to the EMT
phenotype, we utilized flow cytometry analysis to sort cells based on the
expression of CD29 (beta1-integrin) and CD24 (heat-stable antigen), two cellsurface markers whose expression in the CD29hi/CD24+ pattern is associated
with murine mammary gland stem cells (Wang, 2006). As shown (Figure 4.1 A),
the mesenchymal E1KD derivative cells acquired a CD29 hi/CD24+ antigenic
phenotype, whereas this shift was not observed in the parental epithelial cell line.
These results suggest that normal mammary epithelial cells which have
undergone an EMT in response to knockdown of hnRNP E1 expression develop
markers associated with mammary gland stem cells.
We next performed mammosphere assays to further assess the stem-like
characteristics of the E1KD cells. The mammosphere assay is a culture system
in which cells are grown in serum-free and non-adherent conditions. Under these
conditions, differentiated epithelial cells will undergo apoptosis in the absence of
anchorage to a substratum, whereas stem cells can survive the anchorage
independent conditions (Dontu et al., 2005). As demonstrated (Figure 4.1 B),
normal mammary gland epithelial cells are unable to form spheres and cannot
survive serial passages in mammosphere assay conditions. In contrast, the
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E1KD cells readily formed mammospheres and maintain their self renewal
capacity over multiple passages.
While the mammosphere assay offers an in vitro analysis of the selfrenewal capacity of cells, a more rigorous approach for a qualitative analysis of
the self-renewal phenotype, and of the capacity to differentiate involves the in
vivo regeneration of an entire mammary gland ductal tree (Stingl et al., 2005). As
diagramed in Figure 4.1 C, the endogenous epithelium is first surgically removed
from a 3-week old mammary gland of a virgin female mouse. Cells are then
injected into the cleared mammary fat pad and regeneration of a mammary gland
ductal tree is assessed after 6 weeks by whole mount staining of the dissected
gland. As shown (Figure 4.1D), transplantation of NMuMG cells into cleared
mammary fat pads were unable to regenerate the mammary gland ductal tree
(Figure 4.1 D; left panel). In contrast, the E1KD cells, which were stably
transfected with a constitutively expressed green fluorescent protein (GFP)
construct, were validated for their in vivo repopulating activity. As demonstrated
by whole mount staining and fluorescence microscopy, transplantation of E1KD
cells into cleared fat pads were able to regenerate an entire ductal tree (Figure
4.1 D; right panels). These various observations demonstrate that NMuMG cells
which have undergone an EMT in response to modulation of hnRNP E1
expression levels, and thus modulation of the BAT mRNP complex, acquire
stem-like characteristics associated with mammary gland stem cells.
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E1KD cells increase mammosphere formation in normal mammary
epithelial cells.
Recent findings have demonstrated that a combination of both autocrine
and paracrine signals are required to promote cells to undergo an epithelialmesenchymal transition in addition to acquiring self-renewal traits associated
with stem cells (Scheel et al., 2011). Furthermore, there is now substantial
evidence to suggest that mesenchymal and cancer stem cells are able to
promote mammosphere formation in normal epithelial cells by establishment of
cytokine networks and microenviromental signals which effect signaling and
promote cell survival (Klopp et al., 2010; Liu et al., 2011; Korkaya et al., 2011).
Given these finding, we sought to test the hypothesis that secreted factors from
E1KD cells in conditioned media can mediate mammosphere formation in normal
mammary epithelial cells by establishing paracrine signaling networks. To test
this hypothesis, NMuMG cells stably transfected with a constitutively expressed
red fluorescent protein (RFP) construct, and E1KD-GFP cells were initially cocultured in various proportions in a mammosphere assay (Figure 4.2 A, B).
NMuMG cells plated with E1KD cells were found to interact as spheres as early
as day three after plating and displayed a dose-dependent increase in
mammosphere formation (Figure 4.2 A). In addition, fluorescence microscropy
validated the proportional presence of NMuMG-RFP and E1KD-GFP cells in the
mammospheres (Figure 4.2B).
We next investigated whether direct cell contact between E1KD and
NMuMG cells was required by determining the effect of E1KD conditioned media
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(E1KD-CM) on mammosphere formation. E1KD-CM was generated by growing
E1KD cells in mammosphere culture conditions for 7 days. NMuMG cells were
then plated in mammosphere culture with an increasing percentage of volume of
E1KD-CM (Figure 4.2 C, D). In comparison to E1KD cells, NMuMG cells alone
were not able to form mammospheres (Figure 4.2 C, D). However, a dosedependent increase in mammosphere formation was detected when NMuMG
cells were plated with as little as 10% E1KD-CM. These results suggested that
E1KD secreted factors could mediate the acquisition of the self-renewal
phenotype required for mammosphere growth.
Evidence for ILEI and Stat3 phosphorylation in mediating hnRNP E1 effects
on mammosphere formation.
EMT-associated signaling pathways, including TGF and Wnt signaling,
have been shown to mediate both the EMT phenotype and the acquisition of selfrenewal and stem-like characteristics in normal mammary epithelial cells (Scheel
et al., 2011). In addition, it has been demonstrated that mesenchymal stem cells
can stimulate a variety of tumor-related functions including proliferation, cell
renewal, EMT, and metastasis through the paracrine production of cytokines
such as secreted IL6 and activation of STAT3 signaling (Liu et al., 2011). Given
the ability of E1KD-CM to support mammosphere growth of normal mammary
epithelial cells, we hypothesized that promotion and maintenance of the stem-cell
state may depend on activation of similar paracrine loops. Initially, we analyzed
activation of STAT3 signaling in NMuMG and E1KD cells by immunoblot analysis
(Figure 4.3 A). Treatment of NMuMG cells with TGF induced phosphorylation of
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STAT3 in a time-dependent manner, whereas STAT3 was constitutively
phosphorylated in the E1KD cell line irrespective of TGF-treatment. In addition,
STAT3 phophorylation was shown to be inhibited in NMuMGs in the presence of
LY294002, a PI3K inhibitor (Figure 4.3 A). These results suggested that STAT3
activation may be caused by effectors downstream of the BAT mechanism since
phosphorylation of STAT3 was mediated by modulation of hnRNP E1 expression
levels, and displayed a TGF-dependent and LY2940042-sensitive increase in
NMuMG cells.
Our work (Chaudhury et al., 2010), and those of others (Wearner et al.,
2006), have shown that ILEI is indispensable during TGF-mediated EMT.
Although the exact mechanism for how ILEI exerts its biological effects is not
completely understood, a recent report has implicated STAT3 as a downstream
signaling molecule of ILEI (Lahsnig et al., 2009). To determine whether ILEI may
be playing a role in the observed stem-like phenotype, we performed a
comparative analysis of ILEI secretion in E1KD and NMuMG conditioned media
from cells grown on either adherent plates in normal growth media, or from cells
cultured in mammosphere conditions. NMuMG or E1KD cells were seeded on
adherent dishes and treated ±TGF (24h). After washing with PBS, the cells
were incubated an additional 18h in serum-free media. The media was then
collected, separated by SDS-PAGE, and subjected to immunoblot analysis. As
shown in Figure 4.3B, endogenous and secreted levels of ILEI were induced by
TGF-stimulation in NMuMG cells, whereas ILEI expression and secretion was
constitutive in E1KD derivative cells irrespective of TGF-treatment. Next, we
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assessed the presence of ILEI by sandwich ELISA from media conditioned by
either NMuMG or E1KD cells grown in mammosphere conditions. As shown in
Figure 4.3C, ILEI secretion was significantly higher in the E1KD conditioned
mammosphere media compared to the NMuMG mammosphere conditioned
media. Additionally, ILEI could be successfully immunodepleted from the E1KD
conditioned media (Figure 4.3 C).
We next investigated whether E1KD conditioned mammosphere media
(E1KD-CM), could induce STAT3 phosphorylation. NMuMG cells treated with
E1KD-CM for various times displayed a time-dependent increase in phospoSTAT3 levels as early as 5 minutes, whereas total STAT3 levels remained
unaffected. We next assessed whether immunodepletion of ILEI from the E1KDCM media could prevent STAT3 phosphorylation. NMuMG and E1KD cells
treated ±TGF (24h), and NMuMG cells treated with either E1KD-CM or ILEIimmunodepleted E1KD-CM were subjected to SDS-PAGE and immunoblot
analysis.

As

shown

(Figure

4.3

E)

TGF-stimulation

induced

STAT3

phosphorylation in NMuMG cells, whereas phospho-STAT3 levels were
constitutively

high

in

the

E1KD

cells

irrespective

of

TGF-treatment.

Comparitively, NMuMG cells treated with E1KD-CM were able to induce STAT3
phosphorylation, whereas immunodepletion of ILEI from E1KD-CM prevented
STAT3 phosphorylation. Taken together, these results provided evidence
suggesting that ILEI may play a role in mediating hnRNP E1 effects on
mammosphere formation via activation of STAT3 signaling.
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Figure 4.1: Modulation of hnRNP E1 expression in normal mammary gland epithelial cells
mediates stem-like characteristics. (A) Single cell suspensions of NMuMG or E1KD cells were
stained with cell surface markers CD29-FITC or CD24-PE antibodies and analysed by flow
cytometry. (B) Bar graph depicted number of mammospheres formed over multiple passages by
NMuMG or E1KD cells (left); Phase-contrast images of mammospheres seeded by NMuMG or
E1KD cells (right). (C) Diagram depicting mammary gland repopulation assay. (D) Mammary
gland repopulation by 5,000 cells. Results of whole-mount analysis at 6 wks after transplant.
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Figure 4.2: E1KD secreted factors mediate the acquisition of the self-renewal phenotype
required for mammosphere growth. (A) Number of NMuMG mammospheres formed when
plated in mammosphere co-cultures increased with an increasing percentage of E1KD as
compared to NMuMG cells alone. (B). Low-magnification image of NMuMG-RFP and E1KD-GFP
cells (4:1 co-culture) demonstrating integrated mammosphere formation. (C) Number of NMuMG
spheres after plating in the presence of an increasing percentage of volume of E1KD-CM. (D)
Images of suspension cultures of E1KD spheres (top panels) or NMuMG suspensions cultures
with and without 25% E1KD-CM (bottom panels).

102

Figure 4.3: Evidence for ILEI and Stat3 phosphorylation in mediating hnRNP E1 effects on
mammosphere formation. (A) Immunoblot analysis examining total STAT3 (-stat3) expression
levels, phorphorylation of STAT3 (-pStat3) and -Hsp90 (control) in lysates prepared from
NMuMG cells treated ± TGF for the times indicated in the presence or absence of LY294002.
(B) NMuMG or E1KD cells were seeded on adherent dishes and treated ±TGF (24h). After
washing with PBS, the cells were incubated an additional 18h in serum-free media. The media
was then collected, separated by SDS-PAGE, and subjected to immunoblot analysis using ILEI, and -Hsp90 (control) and compared to endogenous levels of ILEI. (C) NMuMG or E1KD
conditiond media (CM) was generated by growing cells in mammophere assays for 7 days.
Sandwich EISA was used to examine the levels of ILEI in NMuMG-CM, E1KD-CM, or E1KD-CM
immunodepleted of ILEI. (D) Immunoblot analysis examining total STAT3 (-stat3) expression
levels, and phorphorylation of STAT3 (-pStat3) in lysates prepared from NMuMG cells treated
with E1KD-CM for the times indicated. E1KD cell lysate was used as a control. (E) Immunoblot
analysis examining total STAT3 (-stat3) expression levels, and phorphorylation of STAT3 (pStat3) in lysates prepared from NMuMG and E1KD cells treated ±TGF (24h), or NMuMG cells
treated with E1KD-CM or ILEI-depleted E1KD-CM.
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4.4 Discussion
Numerous reports have implicated breast cancer stem cells as a critical
target for novel cancer therapeutics given their significant role in the initiation,
propagation, recurrence, and therapeutic failures of breast cancer (Morrison et
al., 2008; Massard et al., 2006; Ohno et al., 2003; Piccirillo et al., 2006). Thus, an
understanding of the molecular mechanisms involved in the regulation of breast
cancer stem cells is necessary in order to design effective therapeutic strategies.
Recent reports have provided evidence suggesting that the acquisition of the
tumorigenic and stem-cell phenotype during the metastatic progression of
carcinoma is driven by an epithelial-mesenchymal (EMT) induction (Mani et al.,
2008; Morel et al., 2008). EMT, which was initially studied as a feature of
embryonic development, is also presumed to be required for tumor invasion and
metastasis of carcinoma cells, and is believed to be governed by complex
cytokine and growth factor networks influenced by signals from the neoplastic
microenvironment (Scheel et al., 2011).
An important finding that is built upon in this study is that a single factor,
hnRNP E1, is responsible for silencing a TGF-mediated EMT program through
the collaborative effort of a regulatory BAT element in select transcripts. We have
previously shown that knockdown of hnRNP E1 in mammary epithelial cells
mediates not only the acquisition of an EMT phenotype, but also causes these
otherwise normal, non-invasive epithelial cells to display an inherent tumorigenic
and metastatic capacity. By utilizing a translational-state microarray analysis, we
have identified a cohort of translationally regulated mRNAs that are upregulated
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during TGFβ-induced EMT including known effectors of EMT such as Moesin,
Activin A, and Interleukin-like EMT Inducer (ILEI). Thus the delineation of the role
of this EMT gene signature may aid in elucidating the downstream cellular
pathways that are affected by activation of silenced EMT-transcripts. In the
present study, we provide evidence that normal mammary epithelial cells which
have undergone an EMT in response to modulation of hnRNP E1 expression
levels (E1KD cells), and thus modulation of the BAT mRNP complex, acquire the
ability to form mammospheres in vitro, and have the ability to regenerate cleared
mammary fat pads in mice, properties which are associated with cancer stem
cells. Furthermore, we demonstrate that E1KD cells can effectively enrich and
condition their culture medium with secreted factors that mediate increased
mamosphere formation in normal mammary epithelial cells. One of the secreted
factors identified in the E1KD-conditioned media was the BAT-regulated and
EMT-facilitating transcript ILEI.
In terms of its biological function, several reports have demonstrated that
stable overexpression of ILEI can mediate an enhanced tumorigenic and invasive
phenotype accompanied by nuclear accumulation of phosphorylated STAT3
(Wearner et al., 2006; Lahsnig et al., 2009), however, the molecular mechanism
by which ILEI exerts is biological effects is not understood. Progress in the
identification of the ILEI receptor has been complicated by our current inability to
produce a sufficient biologically active form of ILEI for in vitro studies. Despite
these limitations, our finding that constitutive ILEI secretion by E1KD cells is
sufficient to elicit a biological reponse, as evidenced by induction of STAT3
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phosphorylation, may allow for a more detailed interrogation and manipulation of
the ILEI-dependent signal transduction pathway.
The preliminary results presented in the current study provide evidence for
a unique mechanism whereby EMT induction could elicit a stem-like phenotype
through the establishment of ILEI-induced STAT3 signaling. Activation of STAT3
as a downstream signaling molecule of ILEI offers an attractive scenario given
the role of STAT3 during induction of EMT (Huang et al., 2011) and in selfrenewal of pluripotent embryonic stem cells (Niwa et al., 1998). Interestingly, a
recent report has demonstrated that in malignant glioma-initiating cells (GIC),
TGFpromotes oncogenesis and increases GIC self-renewal through the Smaddependent induction of LIF and the JAK-STAT pathway (Penuelas et al., 2009).
Comparable to E1KD cells, GICs are characterized by their highly oncogenic
potential, self-renewal and multilineage differentiation properties, and their ability
to generate neurospheres. Similarly, our findings that shRNA-mediated
knockdown of hnRNP E1 results in increased mammosphere formation and the
ability to repopulate a mammary ductal tree through multilineage differentation,
may be indicative of activated downstream STAT3 transcriptional programs
mediating the acquisition of a stem-cell like phenotype.

Future studies are

needed, however, to determine the exact role that ILEI plays in either the
promotion or maintenance of the stem-like phenotype observed in hnRNP E1
knockown cells. One would hypothesize that modulation of ILEI expression in
E1KD cells may attenuate not only STAT3 activation but may also modify the
self-renewal ability and capacity for multilineage differentiation. Attenuation of the
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BAT mRNP complex via TGF/Akt2-mediated phosphorylation of hnRNP E1, or
by modulation of hnRNP E1 expression may therefore represent a critical
checkpoint in the downstream activation of cytokine networks governing
acquisition of self-renewal properties during tumorigenesis and metastatic
progression.
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4.5 Materials and Methods
Reagents: Mouse -ILEI was obtained from Abcam.

-pStat3 and -

Stat3 were obtained from Cell Signaling Technology. -Hsp90 and normal mouse
IgG were purchased from Santa Cruz Biotechnology. Secondary antibodies, mouse and -rabbit-IgG-HRP were obtained from GE Healthcare Bio-Sciences.
-CD29-FITC conjugated and -CD24-PE conjugated antibodies were obtained
from BD Biosciences.
Cell culture and treatments: NMuMGs were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal bovine serum, 10 mg/ml
insulin, and antibiotics/antimycotics (100 units/ml penicillin G, 100 mg/ml
streptomycin, and 0.25 mg/ml amphotericin B). E1KD (previously termed SH14)
were generated in the laboratory and have been described (Chaudhury et al.,
2010). TGF2 was a generous gift from Genzyme Inc. and was used at a final
concentration of 5 ng/ml. Where indicated, cells were treated with 10 M of
LY294002 30 min before TGF treatment.
Flow cytometry analyses: Single cell suspensions were subjected to
flow cytometry analysis on a FACS Aria instrument (BD Biosciences) using
standard protocols.
Mammosphere culture: Single-cell suspensions were grown in 100
l/well of DMEM:F12 medium with 1:50 B27 (Invitrogen), 20 ng/mL EGF, 20
ng/mL basic fibroblast growth factor (bFGF) in Corning Costar 3474 96-well
plates at a density of 5,000 cells/mL. Mammospheres were collected by 70-m
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strainer and dissociated with 0.05% trypsin for 15 min to obtain single-cell
suspension.
Transplantation and mammary gland whole mounts: Three-week old
females of NSG mice were used as recipients. Their inguinal mammary glands
were surgically cleared of the endogenous epithelium as described (Brill et al.,
2008). 5000 cells were injected into the cleared fat pads using a 50-L Hamilton
syringe. After 6 weeks, the glands were dissected and the whole mounting was
done as described (Landua et al., 2009).
Immunodepletion of E1KD conditioned media: E1KD conditioned
media (E1KD-CM) was generated by growing E1KD cells in mammosphere
media for 7 days. 0.5ml E1KD-CM was incubated with 10g -ILEI and 100l
protein A sepharose overnight. Immunodepletion was repeated three times.
Sandwich ELISA: E1KD and NMuMG mammosphere culture media was
collected after 7 days, and ILEI levels were determined by sandwich ELISA. The
ELISA plates were coated with -ILEI (Abcam, ab88337) at 10g/ml in carbonate
buffer, pH 9.3. After overnight incubation at 4°C, excess antibody was washed off
with PBST (PBS containing 0.05% Tween-20), and the plates were blocked by
the addition of 3% BSA in PBS. Samples were added and incubated overnight at
4°C. Plates were washed again with PBST, and -ILEI antibody (Abcam,
ab56065) was added at 10 g/ml. After incubation at room temperature for 2 h,
the plates were washed three times with PBST and incubated IgG-alkaline
phosphatase (1:10,000), followed by 1 mg/ml of p-nitrophenyl phosphate
(Sigma). The absorbance was read after 30 min at 405 nm.
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CHAPTER V
GENERAL SUMMARY

Tumor metastasis is the most common cause of mortality in cancer
patients (Ma et al., 2010). Understanding the molecular mechanisms that cause
tumors to metastasize can provide critical knowledge that is necessary for the
development of targeted therapies that have a distinct mechanism separate from
conventional therapeutics. One approach that has yielded important information
in regards to gene function during tumorigenesis and metastatic progression
involves strategies that focus on tumor phenotype and transcriptional array
analysis aimed at identifying cancer-specific ‘signature genes’. However, given
the significant phenotypic heterogeneity in some tumor types and the fact that
mRNA expression profiling (i.e., the transcriptome) does not accurately mirror the
proteome, these approaches often neglect the role of post-transcriptional control
in gene expression (Moore 2005). It has become evident that the 5´-and 3´-
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untranslated regions (UTRs) of mRNA transcripts can significantly impact gene
expression (Merrit et al., 2008).
Gene expression is regulated at multiple synthetic and degradative steps
including transcription, splicing, mRNA transport, mRNA stability, translation,
protein stability and post-translational modification (Hay and Sonenberg, 2004).
Translational control has recently attracted much attention and has been demonstrated to regulate varied physiological processes, such as proliferation,
differentiation, cellular stress, inflammation and carcinogenesis, and at a cellular
level, it is postulated to be energetically and kinetically more efficient, allowing for
more well defined and rigorous regulatory checkpoints (Ruggero et al., 2003;
Sampath et al., 2004; Standart and Jackson, 1994). Efficient mRNA translation
requires a series of protein–mRNA and protein–protein interactions. Structural
elements of the mRNA, including the 5´ cap, 5´-UTR, 3´-UTR and poly(A) tail, are
important determinants of these interactions, and have been implicated in
translational regulation (Mazumder et al., 2003). In particular, structural elements
in 5´-or 3´-UTRs of mRNAs have been shown to be involved in transcript-specific
translational control, and there is accumulating evidence for the special role of 3´UTR cis-regulatory elements during regulation of mRNA localization, stability and
translation initiation (Ostareck et al., 1997; Sachs et al., 1997; Zoladek et al.,
1995). In addition, post-transcriptional regulation of gene expression requires
trans-acting factors consisting of RNA-binding proteins and noncoding RNAs that
affect splicing, nuclear export, decay, cellular localization and translation (Varani
and Nagai, 1998; Cusack, 1999). Identification of RNAs associated with RNA-
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binding proteins in a cellular context is paramount to our understanding of the
post-transcriptional control of gene expression, and expression profiling on a
genome-wide scale is a commonly employed method aimed at identifying RNAs
regulated post-transcriptionally (Keene and Lager, 2005).
Our studies (Chaudhury et al., 2010; Hussey et al., 2011) and those of
others (Waerner et al., 2006; Wang et al., 2010) have demonstrated that
regulation of gene expression at the post-transcriptional level plays an
indispensable role in TGF--induced epithelial–mesenchymal transition (EMT)
and metastasis. It has become evident that cancer cells can dedifferentiate
through activation of specific biological pathways associated with EMT, gaining
the ability to migrate and invade. Thus, EMT has emerged not only as a
fundamental process during normal embryonic development and in adult tissue
homeostasis, but has also been demonstrated to be essential for metastatic
progression (Derynck et al., 2001; Thiery and Sleeman, 2006; Zavadil and
Bottinger, 2005). EMT is associated with changes in cell–cell adhesion,
remodeling of the extracellular matrix and enhanced migratory activity; all
properties that enable tumor cells to metastasize. Numerous cytokines and autocrine growth factors, including TGF-, have been implicated in EMT (Bierie and
Moses, 2006).
We have identified a transcript-selective translational regulatory pathway
in which a ribonucleoprotein (mRNP) complex, consisting of heterogeneous
nuclear ribonucleoprotein E1 (hnRNP E1) and eukaryotic elogation factor 1-A1
(eEF1A1), binds to a 3´-UTR regulatory TGF-activated translation (BAT)
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element and silences translation of Disabled-2 (Dab2) and Interleukin-like EMTinducer (ILEI), two mRNAs involved in mediating EMT. TGF- activates a
kinase cascade terminating in the phosphorylation of hnRNP E1 by isoformspecific stimulation of protein kinase B/Akt2, which induces the release of the
mRNP complex from the 3´-UTR element, resulting in the reversal of
translational silencing and increased expression of Dab2 and ILEI transcripts
(Chaudhury et al., 2010). We have previously shown that shRNA-mediated
silencing of Dab2 and ILEI in normal murine mammary gland (NMuMG) cells is
sufficient to inhibit TGF-mediated EMT as analyzed morphologically and by
loss of upregulation of N-cadherin and vimentin, mesenchymal cell markers,
whereas their overexpression does not induce constitutive EMT, independent of
TGFβ signaling (Chaudhury et al., 2010; Prunier and Howe, 2005). Thus Dab2
and ILEI are required, but not sufficient, for TGFβ-induced EMT. Hence, we,
and others based on our studies (Evdokimova, 2012), hypothesized that there
are other mRNAs that are being silenced by hnRNP E1 in a similar fashion, and
which

cumulatively

contribute

to

TGFβ-induced

EMT.

By utilizing

a

translational-state microarray analysis (also known as polysome profiling), in
which differential sedimentation is used to separate the nontranslating,
nonpolysomal pool of transcripts from the actively translating, polysomeassociated transcripts, and intersecting this data with a RIP-Chip analysis, we
have identified a cohort of translationally regulated mRNAs that are upregulated
during TGFβ-induced EMT and follow the same pattern of regulation as Dab2
and ILEI.
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Mechanistically,

we

have

delineated

a

novel

transcript-selective

translational pathway and demonstrated that two proteins, hnRNP E1 and
eEF1A1, constitute an mRNP complex that binds to the 3´-UTR of these mRNAs
and regulates their translation in a TGF-dependent manner (Hussey et al.,
2011). This represents an unusual case of agonist- or stimulus-dependent
upregulation of translation through a 3´-UTR element. Our data also suggest that
TGF-regulated translation is mediated through eEF1A1 function during the
translational elongation step as opposed to numerous other examples where
translational control occurs at the initiation step (Curtis et al., 1995; Beckman et
al., 2005; van der Kelen et al., 2009). Thus, analysis and elucidation of this posttranscriptional regulatory pathway is of note in that it allowed for the identity of
‘EMT signature’ genes.
These findings may also have significant implications towards potential
prognostic and clinical applications. Our data demonstrate that Akt2-mediated
phosphorylation of Ser43 of hnRNP E1 is a trigger for the release of binding and
translational silencing mediated by the mRNP complex through the 3´-UTR of
‘EMT inducer’ mRNAs. Thus, Ser43 represents a key regulatory site; in the
dephosphorylated

state

it mediates translational silencing, whereas its

phosphorylation, in response to TGF, relieves translational silencing and allows
transition to the mesenchymal phenotype. If, in fact, the EMT transition is
reflective of the metastatic process, then one might predict that the
phosphorylation status of Ser43 may be indicative of metastatic progression and
the prognosis of patients.
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Investigation and modulation of the EMT process has been the focus of
intense investigation, yet few confirmed and bona fide EMT mediators have been
identified (Kang and Massagu, 2004; Pradet-Balade et al., 2001; Ramswamy et
al., 2003). We postulate that the continued delineation of the role of the identified
target transcripts during EMT and the development of modulators of the BAT
translational regulatory pathway will allow for its interrogation and manipulation
during the EMT transition in physiological and pathological situations. However,
further studies are needed to understand this transcript-selective translational
pathway in human patients, as opposed to cultured cell lines, and for its potential
manipulation through targeted therapeutics.
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